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Zusammenfassung 
APC/Ccdh1 spielt eine wichtige Rolle in der Regulation der Zellzyklusprogression 
durch Markierung von Proteinen für die Degradation durch das Proteosome.  
In einem  “Yeast-Two-Hybrid Screen” wurde Gadd34 als neuer Interaktionspartner für 
Cdh1 gefunden. Gadd34 ist ein bekannter Regulator der integrierten Antwort auf 
endoplasmatisches Retikulum Stress infolge einer Akkumulation von falsch 
gefalteten Proteinen im ER. Diese Bedingungen sind häufig in soliden Tumoren 
durch Hypoxie and Mangelversorgung zu finden. 
Im Rahmen dieser Arbeit wurde die biologische Funktion der Interaktion zwischen 
Gadd34 and Cdh1 analysiert. Co-Immunopräzipitations-Versuche zeigten die 
spezifische Interaktion zwischen Cdh1 and Gadd34 in humanen Zellen nach 
Überexpression. Es wurde auch nachgewiesen dass, der C-Terminus von Gadd34 
für die Interaktion mit Cdh1 ausreichte. Darüber hinaus wurde in His-
Ubiquitinierungs-Versuche gezeigt, dass Überexpression von Cdh1 zur 
Ubiquitinierung von Gadd34 führt. Dieses war von der Menge des überexpremierten 
Cdh1 abhängig. Eine Abnahme in der Ubiquitinierung von Gadd34 erfolgte nach 
Überexpression von Cdh1 Inhibitoren.  
Analysen zeigten, dass APC/CCdh1 die Degradation von Gadd34 unter 
physiologischen Bedingungen reguliert: die Menge und die Stabilität von Gadd34 war 
größer wenn in Zellen, die durch Glucoseentzug gestresst wurden, Cdh1 depletiert 
war. In diesen Zellen blieb Gadd34 länger detektierbar nachdem Abschalten des 
Stresses. Insbesondere konnte gezeigt werden, dass Ausschalten  von Cdh1 zur 
Stabilisierung von Gadd34 führte.  Es wurde auch nachgewiesen, dass das 
Ausschalten von Cdh1 die Viabilität von ER gestressten Zellen reduziert. Dieser 
Effekt korrelierte mit höherer Akkumulation von Gadd34. In der Tat konnte durch eine 
Co-Depletion von Gadd34 die Viabilität erhöht werden. Diese Daten weisen 
daraufhin, dass Cdh1 die Viabilität der ER gestressten Zellen durch die Modulation 
von  Gadd34 Menge kontrolliert.  
Die vorgestellten Ergebnisse deuten drauf hin, dass mit der Inhibition von Cdh1 
durch seine Rolle in der ER Stress Antwort eine vielversprechende Strategie zur 
Eliminierung von Krebszellen entwickelt werden könnte. 
11 
 
 
Summary 
APC/Ccdh1 plays an important role in regulating the cell cycle progression by 
marking proteins for degradation by the proteoasome. 
In a yeast-two-hybrid screen Gadd34 was identified as new interacting partner for 
Cdh1. Gadd34 is a known regulator of the integrated response to endoplasmic 
reticulum stress caused by an overloaded of misfolded proteins in the ER. These 
conditions are often found in tumours due to hypoxia and nutrient starvation.  
In this thesis the biological function of the interaction between Cdh1 and Gadd34 was 
analysed. Co-immunoprecipitation assays showed that Gadd34 interacts with Cdh1 
in human cells after overexpression. Furthermore, the C-terminal part of Gadd34 was 
sufficient to promote this interaction. His-ubiquitination assays demonstrated that 
overexpression of Cdh1 leads to the ubiquitination of Gadd34. This ubiquitination 
was enhanced after increasing the level of Cdh1 and decreased after overexpressing 
inhibitors of Cdh1.  
Analyses under physiological conditions revealed that APC/CCdh1 controls Gadd34 
turnover. This was concluded after analysing the levels and the stability of Gadd34 in 
Cdh1 depleted HeLa cells stressed by glucose deprivation. In these cells, Gadd34 
levels were higher under stress conditions and more slowly reduced after removal of 
stress. In particular, Cdh1 depletion resulted in the stabilisation of Gadd34.  
Cdh1 depletion was seen to reduce the viability of cells undergoing ER stress, which 
correlated with high Gadd34 levels. Indeed, a partial rescue was observed after co-
depleting Gadd34 in these cells. This argues for a role played by Cdh1 in controlling 
the survival of ER stressed cells through controlling Gadd34 turnover. 
The results presented in this work suggest that increasing the ER stress and cell 
death by inhibiting Cdh1 could be a promising strategy for eliminating cancer cells.  
Zellzyklus, ER Stress Antwort, ER Stress und Krebs, Cell cycle, ER stress 
response, ER stress and cancer  
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I. Introduction 
A. The Eucaryotic Cell Cycle 
1. General aspects of the Eucaryotic Cell Cycle 
Cell proliferation is a fundamental aspect of life. Cells grow and proliferate by a series 
of highly coordinated events termed the cell cycle. 
The cell cycle is divided into four distinct phases: G1 phase (Gap1), S phase 
(synthesis), G2 phase (Gap2) and M phase. The period between two M phases is 
also termed interphase. Throughout G1, the cell grows by producing proteins and 
duplicating cytoplasmic organelles. Chromosomes are replicated only during S 
phase. In the following G2, the cell continues growing and ensures that the 
conditions are favourable for entering M phase. At this stage of the cell cycle, the 
growth stops and the cell divides in two identical daughter cells (Vermeulen et al., 
2003).  
The M phase is consisting of mitosis and cytokinesis. The mitosis includes prophase, 
prometaphase, metaphase, anaphase and telophase. Spindle assembly and 
preparation of chromosomes for separation occur during prophase and 
prometaphase. During metaphase, all the chromosomes are fully attached to the 
spindle, align to the metaphase plate and await the signal to separate. In the 
following anaphase sister-chromatids separate and microtubules elongate, which pull 
the chromosomes to the opposite poles of the cell. Finally, in telophase a new 
nuclear envelope reforms around each set of separated chromosomes. These events 
are immediately followed by cytokinesis dividing the cell and marking the end of M-
phase (David O Morgan).  
Cell proliferation depends on the availability of growth factors. In the absence of 
nutrients or after induction of differentiation, the progression is restricted in G1 phase 
at a point termed restriction point (R) or point of non-return. At this point, cells can 
leave the cell cycle and enter a quiescent state termed G0. Under certain conditions, 
resting cells can re-enter the cell cycle and proliferate (Hulleman & Boonstra 2001). 
After passing the restriction point, cells become refractory to growth factors until the 
next G1 (Coleman et al., 2001, Foijer & Riele 2006).  
13 
 
  
To make sure that the genetic material is transmitted to the daughter cells with high 
fidelity, the cell cycle machinery elaborates surveillance systems termed checkpoints. 
These systems monitor that the initiation of later cell cycle events dependent on the 
proper completion of the previous one (Vermeulen 2003). Checkpoints can be 
activated by exogenous and endogenous insults causing DNA damage, cellular 
stress or in the absence of growth factors, hormones and nutrients. 
The DNA damage checkpoints for example restrict the cell cycle progression at 
certain stages and provide time for DNA repair before entry into S phase (G1/S 
checkpoint), during DNA replication (intra S checkpoint) and before entry into mitosis 
(G2/M checkpoint) (Karsten & Bartek 2004). Progression through mitosis is inhibited 
by the spindle assembly checkpoint, which is activated when a single kinetechore is 
not properly attached to the mitotic spindle during metaphase (Flatt & Pietenpol 
2000). 
            
 
Generally, the checkpoint system controls the timing and the order of the cell cycle 
events. Often, alteration in either checkpoint control or cell cycle regulation result in 
S 
M 
G1 
Spindle assembly  
Checkpoint G2/M  
Checkpoint 
S Checkpoint 
G1/S  
Checkpoint 
Restriction 
point 
Fig. 1: The Eukaryotic Cell Cycle 
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genomic instability and increase the risk of tumour development (McGowan 2003, 
Negrini et al., 2010 ). 
2. Cell Cycle Regulation by Cyclin/CDKs 
The entry to a cell cycle phase, the progression and the exit from this phase are 
controlled by the activity of cyclin-dependent-kinases (CDKs). CDKs are 
serine/threonine protein kinases, which are activated and regulated through their 
binding to specific proteins termed cyclins at specific stages in the cell cycle. The 
Cyclin/CDKs phosphorylate keys regulators of the cell cycle controlling thereby 
crucial processes such DNA replication, chromosome condensation, spindle 
assembly and disassembly, nuclear division and cytokineses (Thornton 2008). 
The G1 progression, the G1/S transition and re-entry from quiescence are controlled 
by the activity of Cyclin D-CDK2/4 and Cyclin E in combination with CDK2.  Cyclin A 
associates with CDK2 and controls the S-phase. The progression through G2 and M 
phases is regulated by the activity of Cyclin A/CDK1 and Cyclin B/CDK1 
(Satyanarayana & Kaldis 2009).              
 
 
G0 
M 
G2 
S 
G1 
CDK4 
CDK6 
CDK1 
Cyclin D 
Interphase CDK1 
Mitosis 
CDK2 
CDK2 
CDK1 
Cyclin D 
Cyclin E 
Cyclin A 
Cyclin A 
Cyclin A 
Cyclin B 
Fig. 2: The cell cycle progression is controlled by Cyclin/CDK 
activity  
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Cyclin D/CDK4-CDK6 promote the phosphorylation of the retinoblastoma protein 
(RB) and the subsequent release of the transcription factor E2F. The activity of E2F 
controls the expression of genes encoding regulators of the cell cycle progression 
including Cyclin E and Cyclin A. (Fu et al., 2004, Scherr & Roberts 2004). Cyclin E 
and Cyclin A are synthesised sequentially. Late in G1, Cyclin E binds CDK2 and 
continues the phosphorylation of RB resulting in a complete release of E2F and 
expression of genes required for S phase. Cyclin E/CDK2 regulates the G1/S entry 
by regulating the first event of DNA replication including phosphorylation of Cdc6 and 
the subsequent recruitment of the replicative helicase MCM4 (Mini Chromosome 
Maintenance proteins) to the pre-replication complexes assembled at the origin of 
DNA replication (Hwang & Clurman 2005). During S phase, Cyclin A activates CDK2 
and promotes the initiation of DNA synthesis by phosphorylating for example proteins 
involved in DNA replication (Hulleman & Boonstra 2001).  Moreover, the Cyclin 
A/CDK2 activity inhibits re-replication by phosphorylating Cdc6 and Cdt1 preventing 
thereby reloading of MCM4 to the origin of DNA replication (Yam et al., 2002, Coller 
2007).  
At the end of interphase, Cyclin A activates CDK1 and promotes the entry and the 
progression through prophase. Cyclin A/CDK1 activity is essential for chromosomes 
condensation, for the disassembly of the nucleoli, and for activation of Cyclin B/CDK1 
(Furuno et al., 1999). At mitotic entry, Cyclin B/CDK1 activity is required for 
chromosome condensation, nuclear envelope breakdown, mitotic spindle assembly, 
and in controlling the reorganisation of golgi apparatus (Hochegger et al., 2008, 
Satyanarayana & Kaldis 2009).  
 
A variety of signals act to inhibit the activity of CDKs and thereby the cell cycle 
progression. These inhibitory effects are mediated by negative regulators termed 
CDK inhibitors (CDKIs), which inhibit the CDK activity through binding either directly 
to the CDKs or to the Kinase-Cyclin complexes. Two families of inhibitors have been 
identified: firstly, the INK4 family including, p15INK4b, p16INK4a, p18INK4C and p19INK4d, 
which bind to G1 CDKs (CDK4 and CDK6) and inhibit their binding to Cyclin D and 
secondly, the Cip/Kip family includes p21Cip1, p27Kip1 and p57Kip2, which bind and 
inhibit the Cyclin D- E-A-B-/CDK complexes (Besson et al., 2008). 
16 
 
In addition, the activity of CDKs is regulated both positively and negatively by cell 
cycle specific phosphorylation. Whereas the levels of CDKs remain constant, the 
levels of cyclins oscillate during the cell cycle. This is achieved by transcriptional 
regulation and by cell cycle dependent degradation by the ubiquitin-proteasome 
pathway (Hochegger et al., 2008). 
3. The ubiquitin- proteasome pathway  
The ubiquitin is a highly conserved 76-amino acid protein. Covalent attachment of 
multiple ubiquitin molecule targets proteins for degradation by the proteasome. This 
transfer is directed by the activity of 3 enzymes (E1 ubiquitin activating enzyme, E2 a 
ubiquitin conjugating enzyme and a ubiquitin ligase E3 (Burton et al., 2007, Dye & 
Schulmann 2007). The first step in the ubiquitin pathway is an ATP-dependent 
reaction, which catalyses the activation of ubiquitin through creation of high-energy 
thioester bond between the active cysteine of the E1 and the C-terminal residue of 
the ubiquitin (Baker et al., 2005). In the next step the ubiquitin is transferred to the 
E2, which catalyses in combination with the E3 ligase the transfer of the ubiquitin to 
the target protein resulting in an isopeptide bond between the carboxyl group of the 
C-terminal Gly of ubiquitin and an amino group of lysine residue in the target 
substrate (Bie & Ciechanover 2011).  
 
The E3 ligase provides selectivity in substrate recognition and can be divided into 2 
groups, namely the HECT domain E3 ligases and RING finger domain E3 ligase. 
This classification was based on the presence of HECT (Homologous to the Carboxy 
Terminal of the proteolytical member of the family E6-Associated Protein) and a 
RING finger domain, respectively. They are functionally different: whereas activated 
ubiquitin is transferred first from the E2 to a conserved cystein residue within the 
HECT domain, in the second group the activated ubiquitin is directly transferred to 
the substrate. The RING-finger E3 ligases serve as adaptor, which facilitate the 
positioning and the transfer of the ubiquitin from an E2 onto the substrate (Glickman 
& Ciechnover 2001). 
The sequential attachment of ubiquitins to each other by E3 ligase occurs via one of 
the seven-lysine residue present in the ubiquitin (including K6, K11, K27, K29/33, 
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K48 and K63). However the proteasome recognises only lysine11 and lysine-48-
linked formed chains (Hass & Wilkinson 2008, Glickman & Ciechanover 2001 and 
Rape 2011), whereas ubiquitination through the other lysine residues serves as 
signal for non-proteolytic functions (Glickman & Ciechanover 2001, Bie & 
Ciechanover 2011).   
The ubiquitination reaction is reversible. The ubiquitin is removed from the protein 
through the action of cystein protease termed deubiquitinatting enzymes (DUBs). In 
addition, DUBs play a role in recycling free ubiquitin to the ubiquitin pathway 
(Glickman & Ciechnover 2001, Komander et al., 2009). 
 
 
 
Fig. 3:The Ubiquitin-Proteasome Pathway (according to Nakayama 2006) 
 
Together, the ubiquitin pathway regulates different cellular processes through both 
proteolytic and non-proteolytic mechanisms (Ciechanover 2005, Lecker et al., 2006). 
This depends on the number of the ubiquitin attached to the target protein and the 
lysine residues involved in the formation of the ubiquitin chain (Glickman & 
Ciechanover 2001, Robinson & Ardley 2004). 
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Two E3-ligases are involved in the regulation of the cell cycle progression, namely 
the SCF (Skp1-Cul-F box protein) and the APC/C (anaphase promoting complexes or 
cyclosome). Both of them are members of the RING-Finger family of E3 and contain 
subunits with both cullin and RING finger domains.  
Despite the similarity in the structure SCF and APC/C are functionally different. The 
activity of the SCF complexes is mainly needed in the regulation of G1/S transition, 
during G2 and early M phase, while the activity of APC/C is required for progression 
through mitosis and during G1 (Vodermaier 2004).  
 
4. Cell Cycle Regulation by the APC/C  
4.1 APC/C and activators 
The APC/C is a 1,5-MDa protein complex. Genetic and biochemical analysis 
identified 13 subunits. Apc2, Apc11, Apc10 (Doc1) and Apc3/Cdc27 are the well-
characterised subunits, whereas the exact biological function of the other subunits is 
not well understood and still under investigation (Harper et al., 2002, Foe & Toczyski 
2010).  
Analysis of the APC/C structure in yeast reveals that APC/C is consisting of 3 
subcomplexes; a platform region connected to the catalytic and to the TRP 
subcomplexes (Schreiber et al., 2011, Izawa & Pines 2011). The TRP core is 
composed of Cdc16, Cdc23 and Cdc27 subunits containing a conserved 
tetratricopeptide repeats (Foe & Toczyski 2010). Whereas Cdc23 connects TRP to 
the platform, Cdc27 is involved in the binding of the two coactivators Cdc20 (Fizzy) 
and the Cdh1 (fizzy related protein) to the APC/C thereby regulating the activity of 
this complexe and substrate recruitment (Peters 2006, Foe & Toczyski 2011). The 
binding to Cdc27 subunit requires the presence of a motif called C-Box and a 
conserved Isoleucine-Arginine (IR-tail) within Cdc20 and Cdh1 (Peters 2006).  Both 
coactivators are characterised by the presence of c-terminal WD40 repeat, which 
recognises and binds APC/C substrates through specific motifs termed the D-box 
(destruction Box) and the KEN-box (consensus KENXXXE/D/N). While the D-Box 
(RXXLXXXN) is recognised by Cdc20 and Cdh1, substrates containing the KEN-Box 
are only targeted for ubiquitination by APC/CCdh1. Other destruction motifs have also 
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been identified such as the A-box (RxLxPSN), O-box, and CRY box (CRYxPS) 
(Leuken et al., 2006). 
The catalytic core is implicated in recruiting the E2 ubiquitin ligase and is consisting 
of the cullin protein Apc2, the RING protein Apc11 and Apc10 (Schreiber et al., 
2011). Apc10 is implicated in binding to and reducing the dissociation of the APC/C 
substrates (Foe & Toczyski 2010). A recent study demonstrates that Apc10 binds the 
Cdc27 subunits and contributes in combination with Cdh1 to the recognition of 
substrates containing D-Box (da Fonseca et al., 2011).    
 
 
 
Fig. 4: APC/C Structure (modified from Smolder & Teodoro 2011). The 
organisation of APC/C in 3 subcomplexes is shown according to the study 
performed by Schreiber et al., 2011 in budding yeast. 
 
Additional mechanisms control the APC/C activity including the phosphorylation of 
APC/C subunits and coactivators and the interaction with regulatory proteins 
(Schreiber et al., 2011). 
CDC20 and Cdh1 bind and activate the APC/C at different stage of the cell cycle, 
which provides selectivity in the substrate recognition and specificity in cell cycle 
regulation. 
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4.2 APC/CCdc20 regulation and functions  
Cdc20 starts accumulating at S phase and peaks at M phase, but it can bind and 
activate APC/C only in early M phase (Yu 2007).  
Several mechanisms exist to control the APC/CCdc20 activity. Emi1 (early mitotic 
inhibitor1) is an inhibitor of the APC/CCdc20 activity. This inhibition is achieved by 
interacting with newly synthesized Cdc20 as pseudo-substrate (Baker et al., 2007, 
Thornton & Toczyski 2008), and binding to the APC core (Pesin & Orr-Weaver 2008). 
Activation of APC/C by Cdc20 is promoted after phosphorylation of Emi1 by Polo-Like 
Kinase1 (PLK1) and its subsequent degradation by the SCFTrCP complexe (Baker et 
al., 2007). The association of Cdc20 to the APC/C is also enhanced by 
phosphorylation of Cdc20 and several APC subunits by mitotic kinases including 
Cdk1 and PLK1 (Peters 2002, Eckerdt & Strebhardt 2006).  
In prometaphase, APC/C with it co-activator Cdc20 initiates the destruction of Cyclin 
A and Nek2 (NIMA-related-kinases). Nek2 is implicated in the regulation of 
centrosome structure (Yam et al., 2002) and separation at the onset of mitosis 
(Nakayama 2006). APC/CCdc20 initiates the metaphase anaphase transition. This 
function can be inhibited by the spindle checkpoint (Peters 2006). Mediator of the 
spindle checkpoint binds Cdc20 and forms the Mitotic Checkpoint Complexe (MCC) 
(acquaviva & Pines 2006, Hardwick & Shah 2010). However, the mitotic checkpoint is 
not affecting the activity of APC/CCdc20 towards Cyclin A and NeK2, which continue to 
get ubiquitinated and degraded by the proteasome (Manchado et al., 2010, van Zon 
& Wolthuis 2010, Izawa & Pines 2011). The MCC disassembles once all 
chromosomes are properly attached to the microtubules. Active APC/CCdc20 targets 
securin and cyclin B for degradation resulting in activation of separase. This protease 
cleaves the Scc1 subunit of cohesion responsible for holding sister chromatids 
together allowing thereby the sister chromatids separation and the anaphase onset 
(Peters 2006). Later in mitosis, Cdc20 becomes subject to APC/CCdh1 dependent 
degradation (see 4-3). 
4.3 APC/CCdh1 regulation and functions 
Although Cdh1 accumulates starting from G2, its binding to the APC/C is inhibited 
during G2 and early M phase by CDK phosphorylation (Skaar & Pagano 2008).  A 
decrease in the CDK activity late in M phase leads to dissociation of Cdc20,
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dephosphorylation of Cdh1, and activation the APC/CCdh1.  It has been reported that 
CDC14 is the phosphatase involved in dephosphorylating Cdh1 in budding yeast.  
Human homologue of CDC14 (h CDC14a) is able to dephosphorylate Cdh1 and to 
activate APC/CCdh1 in vitro, but its involvement in vivo requires further investigation 
(Peters 2002, Bembenek & Yu 2001). 
APC/C with its coactivator Cdh1 continues targeting cyclins for degradation and 
promotes also the degradation of Cdc20. APC/CCdh1 targets other mitotic regulators 
for degradation by the proteasome. This includes Plk1 and Aurora B controlling the 
timing of cytokinesis and driving thereby cells out of mitosis (Li & Zhang 2009, Sigl et 
al., 2009).  
Cdh1 is considered as a master regulator of G1. During this phase, the APC/CCdh1 
activity is required for keeping the activity of CDKs activity at a low level by targeting 
Cyclin A and Cyclin B for degradation.  APC/CCdh1 limits also the level of Cyclin D 
through targeting the transcription factor Ets2 for degradation allowing thereby the 
maintenance of G1. Consistent with this function, APC/CCdh1 targets Skp2 (the 
substrate recognition subunit of the SCF ubiquitin ligase) and its cofactor Cks1 for 
degradation (Liu et al., 2007). This allows the stabilisation of its targets including p21 
and p27 (Bashir et al., 2004, Cunliffe 2004) and results in the inhibition of Cyclin 
E/CDK2 the main regulator of the G1/S transition (Liu et al., 2007, Engelbert et al., 
2008, Bashir & Pagano 2004).  
An additional function contributed to APC/CCdh1 during G1 phase is the regulation of 
DNA replication through controlling the assembly of the pre-replicative complex on 
origin of replication. This function is achieved by ensuring a low level of CDKs activity 
and by promoting the degradation of geminin (an inhibitor of DNA replication factor 
Cdt1) (Peters 2006). In parallel, APC/CCdh1 prevents an early DNA synthesis and 
unscheduled entry into S phase by targeting Cdc6 for degradation (Sakai et al., 2010, 
Smolders & Teodoro 2011). Furthermore, APCCdh1 targets Cdc25A (cell cycle division 
25A) a regulator of Cyclin E/CDK2 and of Cyclin A/CDK2 activity for degradation by 
the proteasome (Skai 2010). 
 
Whereas APC/CCdh1 activity promotes the formation of the pre-replication complex in 
early G1 phase (Sigl 2009, Ayad 2005), inactivation of APC/CCdh1 prevents re-
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replication during S phase. At the G1/S boundary, APC/CCdh1 activity is inhibited by 
several mechanisms. Emi1 inhibits APC/CCdh1 as a pseudosubstrate. This inhibition 
results in the stabilisation of Cyclin A and geminin required for controlling the 
processes involved in DNA replication (Sivaprasad et al., 2007). Increase in CDKs 
activity leads to phosphorylation and dissociation of Cdh1 (Li & Zhang 2009, 
Smolders & Teodor 2011). At this stage, APC/CCdh1 mediates its own degradation 
(Listovsky et al., 2004). During S phase, the abundance of Cdh1 is also controlled by 
the SCF ubiquitin ligase complexe (Benmaamar & Pagano 2005). 
                   
Fig. 5: Correlation between the APC/CCdh1 activity and Cyclins level 
(according to Peter 2006). 
 
5. Other functions of the APC/CCdh1 
5.1 During DNA damage 
In response to DNA damage, distinct mechanisms cooperate to initiate and to 
maintain cell cycle arrest. Several studies implicate Cdh1 in activating the G2/M 
checkpoints and in promoting G2 arrest upon genotoxic stress (Sudo et al., 2001, 
Bassermann et al., 2008). Under these conditions, APC/CCdh1 becomes transiently 
active. Cdc14B is the phosphatase involved in dephosphorylating Cdh1 and in the 
subsequent reactivation of APC/CCdh1 (Wulf & Visintin 2008, Bassermann et al., 
2008). Activated APC/CCdh1 targets Plk1 for proteasome-dependent degradation. This 
results in the stabilisation of two targets of Plk1, namely claspin and the Cdk1 
inhibitor Wee1. Claspin phosphorylates and activates the kinase Chk1, which is 
23 
 
involved together with Wee1 in phosphorylating and inactivating CDK1. Attenuation 
of CDK1 activity promotes the G2 arrest and inhibits mitosis (Bassermann et al., 
2008). 
Interestingly, reactivation of Cdh1 at G2 upon genotoxic stress was only affecting the 
stability of Plk1. Suggesting the existence of other mechanisms involved in regulating 
APC/CCdh1 activity and in protecting other Cdh1 targets from degradation in G2 DNA 
damaged cells (Bassermann et al., 2008). 
5.2 During G0 and in differentiated cells 
APC/CCdh1 activity is not restricted to proliferating cells but covers as well non-
proliferating cells. Several observations point to the implication of APC/CCdh1 in cell 
cycle exit and differentiation. It has been reported that depletion of the APC2 subunit 
of the APC/C results in an inactivation of the APC/CCdh1, accumulation of Skp2 and 
Ets2 and a re-entry of this cell into the cell cycle (Wirth et al., 2004). Therefore, 
APC/CCdh1 activity is most likely necessary to maintain the quiescence state of 
hepatocytes and to prevent a spontaneous re-entry to the cell cycle (Wäsch et al., 
2010).  
 
The importance of Cdh1 during quiescence is thought to be related to the ability of 
APC/CCdh1 to inhibit proliferation through targeting Cyclins for degradation (Coller 
2007, Alexandrow & Hamlin 2004). Skp2 is also a target of APC/CCdh1 during G0. 
This allows the accumulation of p27 and the subsequent inhibition of Cyclin E and 
Cyclin A- associated kinase activity (Leuken 2008). Furthermore and in contrast to 
the above mentioned APC/CCdh1 function concerning the control of the formation of 
the pre-replicative complexe during G1 (see 4-3), APC/CCdh1 prevents the assembly 
of the pre-replicative complex during quiescence. This function is accomplished 
through targeting components and regulators of this complex for degradation by the 
proteasome. This includes Cdc6, geminin and Cyclin A (Coller 2007). 
Once quiescent cells are stimulated to re-enter the cell cycle, Cyclin E and Cyclin 
E/CDK2 activity increase. Cyclin E/CDK2 phosphorylates Cdc6 resulting in its 
stabilisation and binding to origin of DNA replication initiating thereby DNA synthesis 
and promoting a cell cycle re-entry (Ayad 2005). 
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Cdh1 as well as subunits of the APC/C are highly expressed in postmitotic neurones 
(Kim & Bonni 2007). Recent studies revealed that APC/CCdh1 regulates different 
aspects of neuronal function and development. This function is achieved by targeting 
specific substrates for degradation during neuronal growth and differentiation 
(Harmey et al., 2008). APC/CCdh1 inhibits the axonal growth through targeting the 
transcriptional regulators Sno1 and Id2 for degradation (Huynh et al., 2009, 
Stegmüller et al., 2008). Other studies pointed to the importance of APC/CCdh1 in 
controlling neuronal survival. This function is achieved through targeting Cyclin B. 
Degradation of cyclin B inhibits a re-entry to the cell cycle and apoptotic cell death 
(Almeida et al., 2005). It has been reported that inhibition of APC/CCdh1 by 
phosphorylation by Cdk5 stabilises Cyclin B and triggers apoptosis in neurons 
(Maestre et al., 2008). 
Comparative electrophysiological and behavioural studies between Cdh1 
heterozygous knockout mice and the wild type implicate APC/CCdh1 in learning and 
memory by controlling synaptic plasticity (Li et al., 2008, Garcia-Higuera et al., 2008). 
Targets of APC/CCdh1 required for establishing this functions are still unknown (Li et 
al., 2008). Studies in worms and flies give the first evidence for the involvement of the 
APC/CCdh1 in the regulation of synapse morphogenesis and function. This is provided 
by targeting liprin- (regulator of synaptic button numbers and activity) for 
degradation and by controlling indirectly the abundance of the post-synaptic 
glutamate receptors GLR-1 in the ventral nerve cord (Stegmüller & Bonni 2005, Kim 
& Bonni 2007, Yue et al., 2010). In this regard, it will be interesting to investigate 
whether homologues of Liprin- and GLR1 exist in mammals. This will give most 
likely more insight into the importance of APC/CCdh1 in controlling synapse 
morphogenesis and thereby learning and memory (Li 2009). 
 
6. Life without Cdh1 
Although Cdh1 is involved in regulating the mitotic exit, the function of APC/CCdh1 
function in mitosis is not essential (Skaar & Pagano 2008). Evidence suggests that 
Cdh1-deficient cells are able to exit mitosis and to enter G1, most likely due to the 
compensatory effect played by the stabilisation of Cdc20 in the absence of Cdh1 
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(Garcia-Higuera et al., 2008, Li et al., 2008, Li & Zhang 2009). In contrast, G1 phase 
is more concerned in its absence. It has been shown that absence of Cdh1 or 
deregulation of its functions results in an early accumulation of Cyclin A, a 
stabilisation of Skp2 and destabilisation of p27. This results in shortening G1 and 
elongation of S phase (Li 2009), most likely due to activation of checkpoint in 
response to an early onset of and impaired progression through S phase (Wei et al., 
2004, Engelbert et al., 2008, Sigl el al., 2009). 
 
To further analyse the importance of Cdh1 in vivo and in an attempt to generate a 
cdh1 deficient homozygous mice, the Zhang group realised that Cdh1 deficiency is 
embryonic lethal and that the homozygous embryos die at around E9,5 due to 
placenta defect. This was due to inhibition of the endoreplication resulting in a failure 
in the formation of placental giant cells (Li et al., 2008, Garcia-Higuera et al., 2008). 
Malumbres and colleagues gave more evidence for the direct implication of the 
placentas deficiency with lethality observed Cdh1 deficient embryos. By developing 
an embryo model, in which Cdh1 was expressed only in the placenta, they were able 
to rescue these embryos at different stage of developments and 3 days after birth. 
But for unknown raisons the Cdh1 knockout mice die later on, and the survival of 
Cdh1 heterozygous mice was reduced at later age compared to wild type (Garcia-
Higuera et al., 2008, Skaar & Pagano 2008). 
  
Mouse embryonic fibroblasts (MEF´s) derived form Cdh1 knockout embryos are able 
to grow and to divide in culture. But they show a slower and defective exit from 
mitosis (Li et al., 2008).  
In contrast to Cdh1 deficient cells, Cdh1 deficient MEF´s show a slower proliferation 
rate compared to wild type MEF´s and become senescent. This was due to the 
stabilisation of the transcription factor Ets2 and the subsequent upregulation of p16 in 
the absence of Cdh1 (Li & Zhang 2009), whereas in the case of Cdh1 deficient cells 
accumulation of Ets2 promotes proliferation by inducing Cyclin D expression (see 4-
3) (Li 2009). These observations implicate Cdh1 in maintaining the replicative life 
span of the MEF´s. 
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Cdh1 deficient MEF’s show also a high degree of genomic instability manifested by 
multinucleated cells, misaligned metaphase chromosomes and multipolar spindles 
(Skaar & Pagano 2008). Deregulation in the turnover of Cdh1 substrates including 
Plk1 and Aurora A could be a trigger for centrosomal abnormalities, cytokinesis 
defects and aneuploidy (Engelbert et al., 2007, Wäsch et al., 2008). 
Genomic instability can lead also to tumour development during proliferation in the 
absence of Cdh1 (Garcia-Higuera et al., 2008). Accumulating evidences point to the 
tumour suppressor function played by Cdh1 (Wäsch et al., 2008, Garcia-Higuera et 
al., 2008). In fact, many targets of Cdh1 are highly expressed in tumours (Nakayama 
2006). This includes Aurora A, Plk1, Cyclin A, B and Cdc20 and other APC/CCdh1 
substrates such as the potential oncogenes Skp2 (Gao el al., 2009), Ets2 (Li & 
Zhang 2009, Li 2009) and Cdc25A (Sakai et al., 2010).  
Although Jung Cdh+/- heterozygous mice develop smaller induced tumours 
compared to wild type, Cdh1 heterozygous mice were more susceptible to 
spontaneous tumours compared to wild type at later ages. They can develop 
epithelial tumours, which were not detectable in wild type mice. A reduced expression 
of Cdh1 has been also detected in various types of cancer cells (Engelbert et al., 
2008, Wäsch & Engelbert 2005, Skaar & Pagano 2008). However, the mechanism 
involved in reducing Cdh1 expression in tumour cells is still unclear (Garcia-Higuera 
et al., 2008). 
All these evidences suggest that Cdh1 could be a haplo-insufficient tumour 
suppressor (Garcia-Higuera et al., 2008) and point to the importance of regulating the 
APC/CCdh1 activity in preventing genomic instability and tumourogenesis. 
 
B. General aspects of the Endoplasmic Reticulum Stress 
Response  
1. ER function 
 
The endoplasmic reticulum is a central organelle in eukaryotic cells. The ER is 
considered to be the first compartment in the secretory pathway (DuRose et al., 
2006). It is the place of biosynthesis of steroids, cholesterol and many lipids. The ER 
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is involved also in regulating calcium homeostasis, in the synthesis, modification and 
delivery of proteins to their target sites (Schröder & Kaufmann 2005). Proteins are 
translated into the ER lumen by ribosomes localised on the cytosolic surface of the 
ER (Rasheva & Domingos 2009), where they fold to their native conformation by 
undergoing different translational, co-translational and post-translational 
modifications (Shröder & Kaufmann 2005, Schröder 2006). Folding requires two 
classes of proteins namely folding enzymes and chaperones. Folding enzymes 
accelerate the kinetics of reactions involved in the folding process, whereas 
chaperones facilitate proper folding (Hebert & Molinari 2007). Bip/GRP78 is the most 
abundant chaperones in the ER. Bip is involved in controlling many aspects of the ER 
function by facilitating the translocation of newly synthesised proteins to the ER, by 
assisting protein folding and by preventing aggregation of proteins within the ER 
(Kaufman 2002, Hebert & Molinari 2007). The ER function is surveyed by a process 
called Quality Control. This process allows only properly folded proteins to be 
exported to the golgi complex and retains incompletely folded or missfolded proteins 
in the ER in order to complete the folding (Schröder & Kaufmann 2005). Missfolded 
protein can be also exported into the cytosol and become targets for the ubiquitin-
mediated proteasomal degradation in a process termed ER-associated degradation 
(ERAD) (Römish 2005). 
2. ER stress and ER stress response 
Perturbation in the ER functions by changes in calcium concentration, nutrient 
deprivation, increase in the secretory protein synthesis and alterations in the 
oxidation-reduction balance, for example, cause ER stress manifested by an 
accumulation of unfolded proteins in the ER lumen (Schröder & Kaufman 2005).  
 
To cope with this perturbation and to re-establish homeostasis the cell elaborates a 
system termed the ER stress response or the unfolded protein response (UPR).  
The UPR consists of three signalling pathways, mediated by the ER transmembrane 
protein IRE1 (inositol-requiring kinase1), ATF6 (activating transcription factor 6) and 
PERK (double strand RNA-activated protein kinase-like ER kinase). 
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Fig. 6: Pathways activated during the UPR (according to Szegezdi et al., 2006) 
 
Under normal conditions, the three signalling pathways are inactive through 
association of the ER stress sensors with the ER chaperone Bip (Binding IgG 
protein). ER stress conditions induce dissociation of Bip from the ER transmembran 
proteins to bind to missfolded proteins accumulated in the ER. This allows the 
dissociation of ATF6 from the ER membrane, the demerization, autophosphorylation 
of the ER transmembrane proteins PERK and IRE1 and thereby the activation of all 
three ER signalling pathways (Fribley et al 2009). Additional mechanisms controlling 
the ER stress sensing and the subsequent activation of the UPR signalling pathways 
are still under discussion and investigation (Lai et al., 2007). 
3. The UPR signalling and cell survival 
 
The ER stress response is initially cytoprotective and aims to re-establish cellular 
homeostasis. This function is achieved by increasing the protein folding capacity of 
the ER, inhibiting the protein synthesis and activating the ER associated degradation 
(ERAD) to reduce the level of missfolded proteins accumulated in the ER (Szegezdi 
et al., 2006). 
3.1 Incresase in protein folding capacity of the ER 
Activation of IRE1 and ATF6 signalling pathways promotes the transcription of gene 
involved in increasing the folding capacity of the ER. IRE1 is a protein kinase 
endoribonuclease. Activation of IRE1 signalling results in the cleavage of an intron 
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sequence from the mRNA of the X-box DNA binding protein (XBP1), which inhibits its 
translation. Once translated, XBP1 translocates to the nucleus and promotes the 
expression of genes encoding chaperones. XBP1 regulates also the biosynthesis of 
membrane proteins and phospholipids in order to induce membrane proliferation and 
to expand the ER (Schröder 2006). The expression of XBP1 can also be regulated by 
ATF6 signalling pathway. ATF6 is transported from the ER to the golgi after its 
dissociation from Bip. In the golgi, ATF6 becomes subjected to cleavage by specific 
proteases. After translocation to the nucleus, ATF6 promotes the expression of 
genes encoding chaperones, folding enzymes and protein disulfide isomerases 
(Schröder 2006, Kim et al., 2006). ATF6 is also able to promote phosphatidylcholine 
synthesis supporting thereby ER biogenesis independent of XBP1 signalling pathway 
(Tsai & Weissman 2011).   
3.2 Inhibition of protein synthesis 
The third UPR transmembrane sensor is PERK, which is a serine/threonine kinase.  
Activation of the PERK signalling pathway results in the phosphorylation of eIF2- 
(eukaryotic translation initiation factor 2) at serine-51. eIF2- is a translation factor, 
which is in its GTP-bound form responsible for bringing methionine charged tRNA 
(Met-tRNAiMet) to the small ribosomal subunit and the subsequent formation of the 
pre-initiation complexe. This complexe scans the 5´ end of the mRNA for the initiation 
codon AUG.  Before initiating the elongation step in the protein synthesis, the GTP is 
hydrolysed to GDP to release the translation initiation factor. To start another round 
of translation, the guanine nucleotide exchange factor, eIF2B, converts the inactive 
form GDP-eIF2- to active GTP- eIF2-. Phosphorylation of eIF2- prevents the 
exchange of GDP-bound eIF2- for GTP and thereby the formation of a new pre-
initiation complex. This results in the inhibition of general protein synthesis 
(Koumenis & Wouters 2006, Kim et al., 2008). 
 
Phosphorylation of eIF2- can be induced by other forms of cellular stress (Holick & 
Sonnenberg 2005). GCN2 (general control non depressible 2), HRI (heme regulated 
inhibitor of translation) and PKR (double-stranded-RNA-activated protein kinase) are 
other kinases involved in this phosphorylation respectively during amino acid 
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deprivation, heme deficiency and by double-stranded-RNA species produced by viral 
infection for example (Brush et al., 2003, Jiang & Wek 2005, Lee 2009). 
 
Inhibition of general protein synthesis under stress conditions is thought to play a 
cytoprotective function by reducing the protein load. However, specific genes are 
expressed and translated selectively and preferentially during the ER stress. This 
includes the transcription factor ATF4 (activating transcription factor 4). ATF4 in turn 
induces genes involved in amino acid transport, glutathiones biosynthesis, and redox 
regulation (Hussain & Ramaiah 2007, Brush 2003) promoting thereby cell survival 
under ER stress conditions (Fribley 2009).  The translation machinery involved in the 
translation of these genes is different from the one involved in the translation of 
genes expressed under normal conditions. Stress inducible genes are translated in a 
specific mechanism termed cap-independent translation or IRES-mediated 
translation, which requires the existence of internal ribosome entry site (IRES) in the 
5´ untranslated region (UTR) (Holcik & Sonenberg 2005, Jackson 2010). 
 
The Shutoff of protein synthesis induced by the ER stress is transient. The 
translational recovery is regulated in a feedback loop: after activation of the PERK 
pathway, ATF4 induces the expression of GADD34 (growth arrest and DNA 
damage). GADD34 contributes as a subunit of the phosphatase type 1 (PP1) in 
dephosphorylating the eIF2- and thereby in the resumption of protein synthesis 
(Shröder & Kaufman 2005, Boyce & Yuan 2006). Gadd34 was first identified in a 
screen for gens, which were upregulated during UV irradiation in Chinese hamster 
ovary cells (Yagi el al., 2003, Hasegawael el al., 2000). It is induced by other factors 
including DNA damaging agents, growth arrest treatments (Hasegawa et al 2000), 
heat shock, exposure to agents inducing apoptosis (Grishin et al., 2001) and by 
interleukine 6 in myeloid differentiation (Liebermann & Hoffman 2002). 
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Fig. 7: Gadd34 modulates the ER stress response 
 
GADD34 deficient MEF´s show a delay in the resumption of protein synthesis during 
ER stress (Yagi et al., 2003, Kojima et al., 2003) and reduced activation of genes 
induced during ER stress (Bruch & Shenolikare 2008). This suggests that the 
negative-feedback loop played by the GADD34/PPI activity is an important 
mechanism in the regulation of stress-induced gene expression (Novao et al., 2003). 
3.3 Removal of missfolded Proteins  
ER-associated degradation (ERAD) is an additional mechanism activated under ER 
stress in order to eliminate missfolded proteins accumulated within the ER (Römish 
2005). ATF6 and IRE1 – XBP1 signalling pathways are involved in the expression of 
genes coding proteins required for the ER-associated degradation (ERAD), 
especially the membrane protein EDEM (ER degradation-enhancing 1, 2--
mannosidase-like protein) (Zhang & Kaufman 2004). EDEM in combination with the 
ER chaperone calnexin recognises missfolded proteins and promotes their 
translocation to the cytoplasm. These proteins then become subject to ubiquitination 
and proteasomal degradation (Vembar & Brodsky 2008). 
 
Besides the ubiquitin-proteasome system, autophagy or lysosomal degradation is 
another mechanism involved in degradation of missfolded proteins, cytoplasmic 
components and damaged subcellular organelles (Ogata et al., 2006). Autophagy 
started by the formation of double membrane vesicle termed autophagosomes 
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surrounding a part of the cytoplasm. Fusion of autophagosomes with lysosomes 
allows the release of the inner vesicle into the lysosome and the degradation of the 
vesicles by lysosomal hydrolase followed by a release of digested components into 
the cytoplasm (Singletary & Milner 2008). 
Both PERK and IRE1 Signalling can promote the expression of autophagy genes 
(ATG). Activation of autophagy can serve many functions. By promoting the 
degradation of macromolecules for example, autophagy provides nutrients and ATP 
helping thereby cells to survive under and to adapt to extreme conditions during ER 
stress (Vicencio et al., 2008, Ogata et al., 2006, Ding 2006). 
 
4. The UPR signalling and cell death 
In prolonged ER stress, the three axes of the UPR can switch from the pro-survival to 
the cytotoxic response. This function is achieved by activating different genes 
controlling apoptotic and non-apoptotic cell death. 
 
The pro-apoptotic protein Chop (CCAAT/enhancer binding protein (C/EBP) 
homologous protein) also called GADD153 is one of the pivotal effectors of this 
switch. Chop is a transcription factor, which can be induced by PERK, ATF6 and 
IRE1 signalling pathways under severe ER stress (Schröder 2006). It has been 
reported that deletion of Chop protects cells from death induced during severe ER 
stress (Rutkowski et al 2006). The mechanism by which Chop induces death in ER-
stressed cells was the topic of many investigations. Evidences suggest that induction 
of GADD34 by Chop and the subsequent resumption of protein synthesis in stressed 
cells can result in apoptosis (Zhang & Kaufman 2008). Chop/GADD135 can activate 
caspase-3 (Zhang & Kaufman 2004, Bateman). It can suppress the anti-apoptotic 
protein Bcl2 allowing thereby the release and the activation of the apoptotic proteins 
BAK and BAX (Lai et al., 2006). Chop can also promote cell death by inducing TRB3 
(tribbles homologues 3) (Ohaka et al 2005, Verfaillie et al., 2010) and DR5 (death 
receptor 5) (Zhang & Kaufman 2008).  
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Chop induction is not only the mechanism regulating ER stress-induced apoptosis. 
IRE1 signalling can also eliminate damaged cells by activating other apoptotic 
pathways. IRE1 can recruit TRAF2 (tumor necrosis factor receptor-associated factor 
2 to the ER membrane. The interaction between IRE1 and TRAF2 is mediated by JIK 
(cJun N-terminal inhibitory kinase) and results in the activation of ASK1 (apoptotic 
signal regulating kinase) and the downstream JNK pathway leading to cell death. 
JNK activation induces apoptosis during the ER stress through phosphorylation of 
Bcl2 family proteins resulting in the release and the subsequent activation of the pro-
apoptotic proteins Bax and Bid (Lai et al., 2007, Lamara & Scorrano 2009). 
Furthermore, the phosphorylation of Bcl2 by JNK promotes its dissociation from the 
autophagic protein Beclin-1 resulting in increased autophagy followed by increased 
susceptibility to apoptotic and non-apoptotic cell death (Verfaillie el al., 2010).  
Recruitment of TARF2 by IRE1 results also in cleavage and activation of caspase-12 
(Kim et al., 2006, Szegezdi et al., 2003). Activated caspase-12 activates caspase-9, 
which in turn activates caspase-3 and leads to apoptosis (Zhang & Kaufmann 2006).  
 
 
 
   
Fig. 8: Connections between the UPR and the cell death machinery (according 
to Kim et al., 2008). 
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5. UPR and cell cycle 
There is evidences pointing to the connection between the ER stress and the 
regulation of cell cycle progression. This connection is mediated by the activation of 
PERK signalling pathway. Inhibition of protein synthesis by this signalling results in a 
rapid degradation of short lived proteins including the G1 regulator Cyclin D. Loss of 
Cyclin D results in a decrease in Cyclin D/CDK4 activity and release of CKIs. This 
leads to inhibition of the Cyclin E/ and Cyclin A/CDK2 complexes and in arresting the 
cell cycle at G1 (Brewer et al., 1999, Brewer & Diehl 2000). Diehl and colleagues 
suggested also the existence of other mechanisms implicated in the G1/S arrest 
observed upon ER stress. They have demonstrated that ER stress caused by 
glucose deprivation or tunicamycin treatment leads to the activation of p53, which is 
involved as transcription factor in regulating the transcription of gene activated during 
growth arrest and apoptosis. Activation of p53 results in the induction of p21, which 
arrests stressed cell at G1/S (Diehl 2006). p53 is also induced during metabolic 
stress. Another study describes the mechanism linking glucose availability to the 
regulation of growth proliferation and cell cycle progression by activating p53 
pathway. This connection is provided by the activation of AMP-activated protein 
kinase.  AMPK kinase is a metabolic sensor, which senses the increase in the 
intracellular AMP: ATP ratio in response to ATP depletion and initiates the cell cycle 
arrest. AMPK promotes the cell cycle arrest by phosphorylating p53 at serine-15 and 
the subsequent induction of p21 (Jones et al., 2005).  A recent study suggested that 
ER stress can promote also a G2 arrest. The arrest is mediated by p53/47 an isoform 
of p53. p53/47 lacks the first 39 amino acids of the full-length p53 and contains IRES 
entry sites, which allows its translation in a cap-independent manner after activation 
of PERK-signalling pathway  (Bourougaa et al., 2010). 
Besides reducing the protein load, the cell cycle arrest can be considered as an 
additional cyto-protective aspect of the activated PERK signalling pathway (Brewer & 
Diehl 2000). 
 
6. UPR and cancer 
The microenvironment of solid tumours is characterised by Hypoxia, low pH and 
heterogeneities in nutrient supply due to impaired vascularisation. Through all these 
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conditions, tumour cells experience ER stress and respond by activating the UPR. 
Several studies reported that the UPR is activated in different type of cancers (Zhao 
& Ackerman 2006, Wang et al., 2008). Consistent with the cytoprotective role played 
by the UPR, activation of this mechanism might allow cancer cells to adapt to the 
stressful conditions and thereby promote tumour growth (Tsai & Weissman 2010). 
The first evidence for the interconnection between cancer development and UPR 
come from the observation that GRP78-knockdown fibrosarcoma cells injected into 
mice do not form or quickly regress (Jomara et al., 1996). It has also been reported 
that chaperones including Grp78 and Grp94 are highly expressed in a variety of 
cancers. Induction of Grp78 promotes cells proliferation (Wang et al., 2010), 
adaptation to tumour microenvironment (Verfaillie et al 2010) and protects tumour 
cells from immune surveillance (Lee 2001). Several other studies confirm the 
importance of the activation of PERK and IRE1 signalling pathways in promoting 
tumours growth and in the adaptation to hypoxia. Both PERK and XBP1 deficient 
MEF’s show an increased cell death under hypoxic conditions and attenuated tumour 
growth in xenograph model (Tsai & Weissman 2010, Verfaillie et al., 2010). There is 
evidences that PERK and IRE1 promote the upregulation of the vascular endothelial 
growth factor VEGF-A. This suggests the role of the UPR in favourising angiogenesis 
and thereby tumours growth (Verfaillie et al., 2010). 
Other studies revealed that activation of the UPR promotes dormancy and even 
survival of dormant tumours. This is achieved by inducing G1 arrest due to inhibition 
of protein synthesis after activation of the PERK signalling pathway. The ATF6 
signalling pathway has been shown to be involved in promoting survival during long 
period of tumour dormancy (Tsai & Weissman 2010). Autophagy can also promote 
survival of cancer cells under stressful conditions by recycling macromolecules and 
providing energy and metabolite in hypoxic regions of the tumours (Rosenfeldt & 
Ryan 2009). The evidence for its requirement came from the observation that 
inactivation of autophagy results in increased apoptotic cells death in tumours cells 
(Ding et al., 2007). 
 
All these evidences detailed above indicate the involvement of the UPR in promoting 
the growth and the survival of tumour under hypoxic conditions and low nutrients. 
The connection between UPR and cancer suggests the possibility of treating cancer 
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by modulating the UPR through pharmaceutical intervention. This can be mediated 
either by inhibiting components of the UPR which provide tolerance to these 
conditions or by activating the pro-apoptotic function of the UPR. Targeting the pro-
survival function played by autophagy during ER stress can eliminate aggressive 
tumours (Li et al., 2011). Inhibition of ATF6 signalling pathway can also be an 
effective tool in blocking survival of dormant tumours (Ranganathan et al., 2006, Tsai 
& Weissman 2010). It has been also shown that suppression of chaperone enhances 
apoptosis and can be an effective target for cancer therapy (Lee 2001, Wang et al., 
2010). Versipelostatin (Kim et al., 2008) and temozolomide are examples of 
compounds showing an antitumor activity by antagonizing Grp78 (Wang et al., 2010). 
UPR-inducer drugs that cause severe ER stress either by inhibiting the proteasome 
(Bortezomib) or by blocking the ERAD (Eeyarestatin1) were also effective in 
eliminating tumour cells (Wang et al., 2010, Verfaillie et al., 2010, Li et al., 2011). -
Tetrahydrocannabinol, an inducer of autophagic cell death derived from marijuana, 
was effective in turning autophagy against tumours and in treating different type of 
cancer cells (Salazar et al., 2009). 
 
All these considerations suggest that manipulation of the ER stress response could 
be an attractive tool in treating cancer cells. However, other observations implicate 
the UPR in the resistance to chemotherapy. By promoting dormancy or growth arrest, 
PERK signalling for example can allow tumours to resist and survive stress during 
cancer treatment (Koumenis & Wouters 2006, Ranganathan et al., 2006). The pro-
survival effect of the chaperones can also provide resistance to chemotherapy (Ying-
yan et al., 2008, Andrieu et al., 2010). It has been also reported that activation of the 
UPR provides resistance to topoisomerase poisons such as etoposide, an effective 
anticancer agent, which inhibits relegation of DNA strands during replication and 
activates DNA checkpoints. Most likely the UPR antagonises the effect of etoposide 
by decreasing the level of DNA topoisomerase due to inhibition of translation (Ma & 
Hendershot 2004).  
Therefore, inhibition of the pro-survival or activation of the pro-apoptotic functions of 
the ER stress response could be useful to overcome the problem of the resistance of 
cancer cells to chemotherapy.  
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In summary, the UPR is biphasic and can either promote or inhibit tumour growth. It 
can also provide resistance or sensitise tumours to chemotherapy. Further 
investigations are necessary to explore and to exploit the mechanism controlling the 
balance between cytoprotective and cytotoxic response of the UPR, which is a big 
challenge and might be an effective way to overcome drug resistance and to cure 
cancer. 
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II. Aim of the thesis 
In order to define new functions of APC/CCdh1, a Yeast-two-hybrid screen was 
performed in our Group. In this screen Gadd34 was identified as a new interacting 
partner for the cell cycle regulator Cdh1. The connection between the cell cycle and 
the ER stress response suggested that the response of cell to ER stress might be 
controlled by Cdh1. 
The ER stress response can promote cell survival and cell death. It was therefore 
aimed to find out whether Cdh1 is involved in one or the other outcomes of ER stress 
response. 
ER stress is often involved in cancer development and therapy. These investigations 
should not only contribute to deeper understanding of ER stress homeostasis but 
might also open the road for potential cancer treatment. 
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III. Material and Methods 
1. Expendable items 
Cover slip 
Freezing tube 
Microscope slides 
Transfer membrane 
Hyperfilm TM ECL 
Whatman 
Centrifuge tubes 
Dialysis tubing 
6 wells plate                                                  
12 wells plate                                                
96 wells plate  
Cell culture dishes 1000x15 mm 
Cell culture dishes 60x15 mm 
Micro tube 1,5 ml   
Filter Tips 0,1-10 ul 
Filter tips 20 ul 
Filter tips 200 ul 
Filter tips 1000 ul     
15 ml tube 
50 ml tube                                   
Menzel-Gläser, Braunschweig 
Sarstedt, Nümbrecht 
Menzel-Gläser, Braunschweig 
PerkinElmer, Rodgau 
Amersham Bioscience, Braunschweig 
Omnilab, Elbingeröder 
Beckmann, Palo Alto 
Pierce, Rockford 
Sarstedt, Nümbrecht 
Sarstedt, Nümbrecht 
Sarstedt, Nümbrecht 
Sarstedt, Nümbrecht 
Greiner Bio-One, Frickenhausen 
Sarstedt, Nümbrecht 
Sarstedt, Nümbrecht 
Sarstedt, Nümbrecht 
Sarstedt, Nümbrecht 
Greiner, Solingen 
Sarstedt, Nümbrecht 
Sarstedt, Nümbrecht 
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2. Equipments 
Agarose Gelelectrophoresis systems  
Centrifuges: 
Centrifuge 5415 D 
Centrifuge Mikro 220 R cooled 
Megafuge 1.0 
Centrifuge “Rotina 38R” 
Centrifuge “L8-55M” 
Chaker vibramax 110                   
Clean Bench        
Easypet 4420                
Electrophoresis power supply 
Fluoresence microscope  
Gel chambers for proteins         
Heater     
Incubator                                                
Magnetic stirrers   
MicroPulser TM       
Microtiterplate luminometer  
Microwave   
Mini-Protein Electrophoresis System 
Mini Trans-Blot cell   
Mixer 5432     
Multipette® plus    
Bio-RAD, Munich 
Eppendorf, Hamburg 
Roth Karlsruhe 
Heraeus, Osterode 
Hettich, Tuttlingen 
Beckman GmbH, Düsseldorf                                                                      
GFL, Burgwedel 
Heidolph, Kelheim 
Hera Safe, Kendro, Osterode 
Sartorius, Göttingen 
Leica DM5000, Leica, Wetzlar 
Bio-RAD, Munich 
Bio-RAD, Munich 
Heraeus Instruments GmbH, Osterode 
Heidolph, Kelheim 
Bio-RAD 
Tecan Deutschland GmbH, Crailsheim 
Bauknecht, Stuttgart 
Bio-RAD, Munich 
Bio-RAD, Munich  
Bio-RAD, Munich  
Eppendorf, Hamburg 
InoLab, Weilheim 
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pH-meter 
Photometer 
Pipett 
Pipetman 
Power supplies    
Sonifier UP 200H                                        
Thermo cycler   
Thermomixer 5436       
ThermoStat plus  
Vortex-Genie           
Water baths                                                                                                                                                                                                                                                                                                           
Eppendorf, Hamburg 
Eppendorf, Hamburg 
Hirschmann, Eberstadt 
Bio-RAD, Munich  
Gilson, Villiers le Bel 
Bio-RAD, Munich 
Hielscher, Stahnsdorf 
MWG-Biotech  AG, Ebersberg 
Eppendorf, Hamburg 
Eppendorf, Hamburg 
Janke & Kunkel, Staufen 
  
 
3. Softwars 
Microsoft Excel 2007 (Microsoft Inc., Remond, Washington, USA) 
Microsoft Word 2007 (Microsoft Inc., Remond, Washington, USA)  
FlowJo Version 7.3 (Tree Star Inc., Ashland, USA) 
BD Cell Quest ProTM (BD Biosciences, Mississauga, USA) 
ImageJ 1.42 (Free Software Foundation, Inc., Boston, USA) 
Adobe Photoshop 7.0 (Adobe Systems, San Jose, USA) 
MacVector Version 10.1 (MacVector Inc, Cambridge, United Kingdom)  
 
4. Chemicals 
Acetic acid       Baker, Griesheim 
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Aceton    
Acrylamid-solution (30%) Mi 
37,5:1  
Ampicillin 
Annexin V conjugates 
Agar      
Agarose     
Ammoniumacetat   
Ammoniumsulfat  
Ampicillin 
Antifoam 
A-sepharose bead      
BactoTM peptone   
Benzamidine 
BM Cyclin 
ß-Glycerophosphat      
ß-Mercaptoethanol    
Bromophenol bleu   
Boric acid    
Calcium chlorid    
Cesium chloride 99%                                                                                                                                                                                                                 
DAPI   
DEPC 
DMEM 
dNTP 
Doc 
EDTA 
EGTA 
Ethanol 
Ethanolamine    
Ethidiumbromide   
FCS 
Formaldehyde solution min. 
37% free from acid   
Gelatine     
Glucose                                                                       
GlutaMax                                                          
Merck, Darmstadt 
AppliChem, Darmstadt 
 
AppliChem, Darmstadt 
Invitrogen 
AppliChem, Darmstadt 
Bioline, Luckenwalde 
AppliChem, Darmstadt 
AppliChem, Darmstadt 
AppliChem, Darmstadt 
Sigma-Aldrich, Schnelldorf 
GE Healthcare, Munich 
Becton Dickinson, Heidelberg 
Sigma-Aldrich, Schnelldorf 
Roche, Mannheim 
AppliChem, Darmstadt 
AppliChem, Darmstadt 
AppliChem, Darmstadt 
Merck, Darmstadt 
AppliChem, Darmstadt 
AppliChem, Darmstadt
AppliChem, Darmstadt 
AppliChem, Darmstadt 
Invitrogen, Karlsruhe 
Fermentas,  St. Leon-Rot 
AppliChem, Darmstadt 
AppliChem, Darmstadt 
AppliChem, Darmstadt 
Meck, Darmstadt 
Sigma-Aldrich, Schnelldorf 
AppliChem, Darmstadt 
Biochrom, Berlin 
Merck, Darmstadt 
 
Sigma-Aldrich, Schnelldorf 
AppliChem, Darmstadt 
Invitrogen, Karlsruhe 
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Glycine   
G-sepharose beads   
Guanidine thiocyanate                                                    
HEPS      
 30% H2O2 
HiPerfect   
Imidazole         
Isopropanol                                                                    
Kanamycinesulfate     
Lauroylsarcosine                                                      
Luminol min 97%, HPLC      
Magnesium chloride                                                        
Methanol    
MG132 
Natrium  
Natriumchlorid                              
Nocodazole   
Nonfat dried milk powder 
Nonidet P40 
p- Cumaric acid  
Penicillin- Streptomycin solution                                                                
Pepstatin A         
PfuTurbo DNA polymerase            
Phenol        
Polyethylenimine   
Ponceau S solution                                                                    
Potassium acetate                 
Potassium chlorid                                         
Potassium dihydrogen 
phosphate                                    
Prolong® gold antifade reagent                                     
Propidium iodid        
Proteinase K 
Restriction enzymes                                               
SDS                                                                                                                                                         
Sodium carbonate                                                           
Sodium chloride                                                               
AppliChem, Darmstadt 
GE Healthcare, Munich 
Sigma-Aldrich, Schnelldorf 
AppliChem, Darmstadt 
Sigma-Aldrich, Schnelldorf 
Qiagen, Hilden 
AppliChem, Darmstadt 
Merck, Darmstadt 
AppliChem, Darmstadt 
Sigma-Aldrich, Schnelldorf 
Sigma-Aldrich, Schnelldorf 
AppliChem, Darmstadt 
AppliChem, Darmstadt 
Sigma-Aldrich, Schnelldorf   
AppliChem, Darmstadt 
AppliChem, Darmstadt 
Sigma-Aldrich, Schnelldorf   
AppliChem, Darmstadt 
AppliChem, Darmstadt 
Merck-Schuchard, Darmstadt 
Invitrogen, Karlsruhe
 
AppliChem, Darmstadt 
PfuTurbo DNA polymerase  
Roth, Karlsruhe 
Sigma-Aldrich, Schnelldorf  
AppliChem, Darmstadt 
AppliChem, Darmstadt 
AppliChem, Darmstadt 
Merck, Darmstadt 
Invitrogen, Karlsruhe 
 
Fluka, Steinheim    
AppliChem, Darmstadt 
NEB, Fermentas
AppliChem, Darmstadt    
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Sodiumdihydrogenphosphat                                           
Sodium floride                                                                                                                          
Sodium pyrophosphate                                                   
Talon metal affinity resins                                          
TEMED                                                                            
Thymidine 99-100%    
Thermo Pol buffer          
Tris                                                                                   
Triton X 100                                                                     
Trypsin/EDTA solution   
Trypton 
Tunicamycin 
Tween-20                                                                         
Urea                                                                            
Vanadat                                                                           
Yeast extracts                                                                   
Xylenecyanol  
AppliChem, Darmstadt     
AppliChem, Darmstadt
AppliChem, Darmstadt      
AppliChem, Darmstadt                                                                                                                                                                                                                                                                    
Sigma-Aldrich, Schnelldorf 
Becton Dickinson, Heidelberg 
AppliChem, Darmstadt 
Sigma-Aldrich, Schnelldorf 
Biolabs, Frankfurt 
AppliChem, Darmstadt 
AppliChem, Darmstadt 
Biochrom, Berlin 
AppliChem, Darmstadt 
Sigma-Aldrich, Schnelldorf 
AppliChem, Darmstadt 
AppliChem, Darmstadt        
AppliChem, Darmstadt   
AppliChem, Darmstadt    
AppliChem, Darmstadt  
 
 
 
 
5. Cell lines 
 
-HeLa cells are a human epithelial cervical cancer. HeLa cells were derived from 
cervical cancer cells taken from Henrietta Lacks, a patient who eventually died of her 
cancer 
- U2OS is a human osteosarcoma cell line cells. The U2OS cell line was cultivated 
from the bone tissue of a fifteen-year-old human female suffering from osteosarcoma. 
- HEK293 cells or Human Embryonic Kidney 293 cells: are a specific cell line 
originally derived from human embryonic kidney cells grown in tissue culture. HEK 
293 cells were generated by transformation of cultures of normal human embryonic 
kidney cells with adenovirus.  
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- HCT116 cells are epithelial human colorectal carcinoma cells. HCT116 cells were 
originally isloted from a mal patient. These cells have a wild-type P53 genotype. 
    The cells used in this work were cultivated in DMEM medium suplemented with: 
GlutaMAX  
FCS 
Penicillin/Streptomycin 
2 mM 
10% 
100 µg/ml 
 
   The cells were frozen in 10 % DMSO in FCS (=Freezing medium) 
6. Buffers and solution 
6.1 Buffers for the cell culture 
 
Dialysis buffer  pH 7,4       
HEPS 
NaCl 
  10 mM 
150 mM 
 
10X PBS          
NaCl 
KCL 
Na2HPO4 
KH2PO4 
137 mM 
 2,7 mM 
100 mM 
    2 mM 
 
The pH was adjusted to 7,4. PBS was sterilised by autoclaving.  
Annexin-binding buffer pH 7,4      
HEPS    10 mM 
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NaCl 
CaCl2 
140 mM 
 2,5 mM 
 
Proteinase K buffer       
Tris pH 8,5 
EDTA  
SDS  
NaCL 
ddH2O 
  100 mM 
      5 mM     
    0,2 % 
   200 mM 
   100 ml 
 
 
6.2 Buffers for bacteria 
1XLB medium    
Bacto-tryptone  
Bacto-yeast extract 
NaCl 
   1 % 
0,5 % 
170 mM 
   
 
The pH was adjusted to 7,0 with 10 M NaOH and the medium was sterilised by 
autoclaving. 
1X agar  
Bacto agar 1 % 
   
Sterilise by autoclaving 
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6.3 Buffers and solution for nucleic acid analysis 
 
10x agarose loading buffer 
Tris pH 7.6 
Glycerol 
Bromophenol blue 
Xylene Cyanol 
 150 mM 
   10 % 
0,25 % 
0,25 % 
     
  
TE buffer 
Tris pH 8,0 
EDTA 
 
10 mM 
  1 mM 
 
 
1x electrophoresis buffer TBE                        
Tris 
Boric acid 
Na2EDTA  pH 8.0 
 
89 mM 
89 mM 
  2 mM  
 
  
Solution for Minipreps 
Solution A (Resuspension solution) 
25 mM Tris pH 7.5 
10 mM EDTA pH 8 
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50 mM Glucose (add after autoclaving) 
Solution B (Cell lysis solution) (fresh) 
0.2 N NAOH 
1% SDS 
Solution C (Neutralisation solution) 
3M  potassium acetate  
11,5 % acetic acid 
DEPC H2O  
DEPC 
ddH2O  
  20 µl 
100 ml 
 
 
Mix underneath the hood! 
Let sit overnight before autoclaving 
 
Solution D for RNA extraction 
Guanidinium thiocyanate 
Sodium citrate pH 7.0 
ß-Mercaptoethanol 
Sodium Lauryl sarcosinate 
Antifoam 
DEPC H2O 
 
    4 M 
  25 mM 
100 mM 
  0,5 %  
  0,1 %  
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6.4 Buffers and solutions for protein extraction and analysis 
6.4.1 Protein extraction 
 
RIPA 
Tris pH 8,0 
NaCL 
NaF 
Na4P2O7 
EDTA 
EGTA 
NP-40 
DOC 
SDS 
 50 mM  
 80 mM  
 50 mM  
 20 mM  
   1 mM  
   1 mM  
   1 %  
   1 %  
0,1 %  
 
NP40 
Tris pH 7,5 
NaCl 
NaF 
Na4P2O7 
EDTA 
ß Glycerolphosphat 
NP-40 
  50 mM 
150 mM 
  50 mM 
  20 mM 
    1 mM 
 10  mM 
0, 5 % 
 
4XSB 
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Tris pH 6,8        
SDS  
Glycerol     
ß-Mercaptoethanol      
Bromophenol blue   
 
0,25 M     
     8 %  
   40 %  
   10 %  
0,05 %  
 
              
 
Protease and phosphatase inhibitors (for 10 ml buffer) 
 Inhibitor of Final concentration 
Vanadat 
Leupeptin 
Leupeptin 
Benzamidin 
Aprotonin 
PMSF 
Tyrosin-phosphatase 
Aspartic-protease 
Serin-cystein protease 
Trypsin, thrombin, Plasmin 
Trypsin, chymotrypsin, Kallikerin 
Serin-protease 
 100 uM 
  0,5 ng/ml 
  2,5 ng/ml 
0,15 mM 
  0,5 % 
  0,5 mM 
Table 1: List of the protease and phosphatase inhibitors 
 
6.4.2 Protein analysis 
 
Separating Gel 
% Acrylamid 7,5 % 10 % 12 % 14 % 15 % 
Acrylamid   2,5 ml  4,1 ml 3,4 ml 2,7 ml 2,45 ml 
Tris pH 8,0   2,5 ml  2,5 ml 2,5 ml 2,5 ml   2,5 ml 
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H2O 4,85 ml  4,1 ml 3,4 ml 2,7 ml 2,45 ml 
10 % SDS  100 ul 100 ul 100 ul 100 ul   100 ul 
TEMED    15 ul    15 ul   15 ul   15 ul      15 ul 
10 % APS  105 ul 105 ul  105 ul  105 ul   105 ul 
Table 2: Recipes of separating gels 
 
Stacking gel 
Acrylamid 
Tris 6,8 pH 
ddH2O  
10 % SDS 
TEMED 
10 % APS 
1,13 ml 
1,75 ml 
  3,2 ml 
   70 ul 
     7 ul 
   70 ul 
Table 3: Recipe of the stacking gel 
 
SDS running buffer (10x) 
Tris pH 8,3  
SDS   
Glycine              
250 mM 
    1 % 
1,92 M 
 
 
Western transfer buffer (10x) 
Tris 
Glycine               
 250 mM   
1,92 M     
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TNT western blot washing buffer (10x)   
NaCL 
Tris pH 7,5     
Tween-20  
 
   1,5 M 
  100 mM 
   0,5 % 
                                       
 
 
 
Urea buffer 
Urea 
Imidazole 
Phosphate buffer pH 8,0 
     8 M  
   10 mM  
  0,1 M 
 
0,1 M phosphate buffer pH 8,0 for 100 ml urea buffer 
1 M Na2HPO4 
1 M NaH2PO4  
93,2 ml 
  6,8 ml                                              
 
Blocking solution     
 Milk powder, nonfat 5 % in TNT 
ECL solution 
Solution 1 
Luminol     250 mM  
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p-cumaric acid  
Tris pH 8,5  
 
    0,4 mM  
    0,1 M 
   
Solution 2 
Tris pH 8,5  
30 % H2O2 
 
    0,1 M 
0,061 % 
 
7. Antibodies 
7.1 Antibody for Western blot 
 
Primary antibody 
Target Source  Working 
dilution 
Manufacturer 
Monoclonal anti-HA (12CA5) 
Monoclonal anti-Cdh1 (DCS-266) 
Monoclonal anti-Gadd34 (D-8) 
Polyclonal anti-Gadd34 (H-173) 
Monoclonal anti-Actin (C-2) 
Monoclonal anti- c-Myc (9E10) 
Polyclonal anti-Bip (3183) 
Polyclonal anti-P-eIF2 (Ser 51) (9721) 
Polyclonal anti-eIF2 (9722) 
Polyclonal anti-Cyclin A (H-175) 
mouse 
mouse 
mouse 
rabbit 
mouse 
mouse 
rabbit 
rabbit 
rabbit 
rabbit 
1:1000 
1:10000 
1: 500 
1: 500: 
1:1000 
1:10000 
1:1000 
1:1000 
1:1000 
1:1000 
Roche 
Sigma 
Santa Cruz 
Santa Cruz 
Santa Cruz 
Sigma 
Cell Signaling 
Cell Signaling 
Cell Signaling 
Santa Cruz 
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Monoclonal anti-Cyclin B1 (GNS1) 
Monoclonal anti-Cyclin D1 (DSC-6) 
Monoclonal anti-Chop (9C8) 
Monoclonal anti-Cdc27 (AF3.1) 
Polyclonal anti-LC3 
Polyclonal anti-P53 (FL-393) 
Polyclonal anti-P21 (C-19) 
Polyclonal anti-Cleaved Caspase-3 (Asp175) 
(9661) 
Polyclonal anti-Sumo-1 (4930) 
Monoclonal anti-Sumo-2/3 (18H8) 
mouse 
mouse 
mouse 
mouse 
rabbit 
rabbit 
mouse 
rabbit 
 
rabbit 
rabbit 
1:1000 
1:1000 
1: 500 
1:1000 
1:1000 
1:1000 
1:1000 
1:1000 
 
1:1000 
1:1000 
 
Santa Cruz 
Neo Markers 
Abcam 
Sigma 
Cell Signaling 
Santa Cruz 
Santa Cruz 
Cell Signaling 
 
Cell Signaling 
Cell Signaling 
Table 4: List of primary antibodies used for western blot 
Secondary antibodies 
Target Working 
dilution 
Manufacturer 
Anti-mouse IgG peroxidase conjugated 1:10000 Amersham, 1,5 mg/ml 
Anti-rabbit IgG peroxidase conjugated 
Mouse TrueBlotTM  HRP-conjugated anti-
mouse IgG ( clone eB144/7A7) 
1:10000 
1:15000 
Amersham, 1,5 mg/ml 
Bioscience 
Table 5: List of secondary antibodies used for western blot 
 
7.2 Solutions and antibodies for immunofluoresence 
Fixation solution                        Paraformaldehyd 3,7 % in PBS 
Permeabilisation buffer             0,1 % triton in PBS 
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Blocking solution                       2 % BSA in PBS 
Primary antibody immunofluoresence 
Target Source Working dilution Manufacturer 
Monoclonal anti-HA-tag (6E2) (Alexa Fluor 
® 488conjugate) 
Monoclonal anti-Myc-tag (4A6) (Alexa 
Fluor ® 555 conjugate) 
Monoclonal anti- Eset (C1C12) 
mouse 
 
mouse 
 
rabbit 
1:50 
 
1:500 
 
1:50 
Cell Signaling 
 
Upstate 
 
Cell Signaling 
Table 6: List of fluorescent-conjugated primary antibodies used for 
immunofluoresence. 
Secondary antibody for immunofluoresence 
Alexa Fluor ® 555 goat anti-mouse      
Alexa Fluor ® 488 goat anti-rabbit                                           
Invitrogen, Karlsruhe 
Invitrogen, Karlsruhe 
Table 7: List of fluorescent-conjugated secondary antibodies used for 
immunofluoresence 
8. Kits 
cDNA synthesis kit  
DNA isolation kit 
DC protein assay kit 
DNA extraction from Agarose gel 
TOPO TA cloning ® Kit for sequencing 
Bio-RAD  
BioLine 
Bio-RAD 
Qiagen 
Invitrogen 
 
9. Nucleic acid 
Plasmids 
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- pCMV vector is designed to allow transient expression in mammalian systems. The 
expression is driven by the human cytomegalovirus (CMV), which promotes a 
constitutive expression of cloned inserts in a wide variety of cell lines. 
- pCS2+ is a multipurpose expression vector originally designed for expressing 
proteins in xenopus embryos. pCS2+ is also useful for high-level transient expression 
in mammalian cells.  
Derivatives of this plasmid have been constructed by fusion of epitope tags  
- pCS2+MT (Myc-tag) allows the expression of proteins fused to 6 copies myc-
epitope tag recognised by the 9E10 monoclonal antibody. pCS2+MT was generated 
by Stolk and colleagues (Roth et al 1991). 
 - pCS2+HA (HA-tag) allows the expression of protein fused to hemagglutinin (HA) 
epitope tag recognised by the polyclonal HA-antibody.  
Oligonucleotides 
All siRNA were purchased from ambion 
Cdh1 siRNA  
Sense    
Anti-sence    
Gadd34 siRNA 
Sense 
Anti-sence    
 
5’UGAGAAGUCUCCCAGUCAGtt3’ 
5’CUGACUGGGAGACUUCUCAtt3’ 
 
5’GUCAAUUUGCAGAUGGCCAtt3’ 
5’UGGCCAUCUGCAAAUUGACtt3’ 
 
Table 8: List of siRNA used for depleting Cdh1 and Gadd34 
 
Primers 
All primers were purchased from operon 
The following primers were used for the generation of GADD34 deletion mutants: 
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Full length GADD34 forward 
Full length GADD34 backward 
N1 forward 
N1 backward 
N2 forward 
N2 backward 
N3 forward 
N3 backward 
AAAAAAGAATTCAAGCCCCAGGCCAAGCACC 
AAAAAATCAGCCACGCCTCCCACTGAGGTC 
AAAAAAGAATTCAATATGGTGAGCGAGAGGCAACC 
AAAAAATCAGCCACGCCTCCCACTGAGGTC 
AAAAGAATTCAAGCCGAGGAAGAGGGAGTTGCTG 
AAAAAATCAGCCACGCCTCCCACTGAGGTC 
AAAAGAATTCAATCAGAAGCAGCCTTAGGAGAAG 
AAAAAATCAGCCACGCCTCCCACTGAGGTC 
 
 
Table 9: List of primers used for generating deletion mutants 
 
GADD34 forward 
GADD34 backward 
HRTP forward 
HRTP backward 
5’GAGGGAGTTGCTGAAGAGGAGGGA3’ 
5’CCTCCGTGGCTTGATTCTCTTCCT3’ 
5’GCAGACTTTGCTTTCCTTGG3’ 
5’GTGGGGTCCTTTTCACCAG3’ 
 
 
Table 10: Primers used for semi quantitative RT-PCR 
 
10. Cell culture techniques 
10.1  Culturing of adherent cell lines 
Adherent cells used in this work were cultured in complete cultivation medium and in 
medium lacking glucose (3-5). All incubations were performed in a humidified 37°C, 5 
% CO2 incubator.  
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The FCS used for the cultivation medium without glucose was subjected to dialysis at 
4 °C under steering to remove all traces of glucose. The dialysis was performed for 
16 hrs and the dialysis buffer (3-6-1) was changed every 4 hrs. 
10.2  Subculturing adherent cell lines 
Adherent cells were subcultured after reaching 70-90 % confluency to prevent culture 
dying. 
Culture medium was removed from the plate, and cells were washed 2 times with 
PBS. To dissociate adherent cells, the plate was incubated in 2 ml trypsin at 37°C for 
1-2 min. The incubation time might differ from cell line to cell line. Cell dissociation 
can be examined under microscope and the proteolytic reaction can be quickly 
terminated by the addition of pre-warmed growth medium. Cells were re-suspended 
with the appropriate volume of medium and 1x106 cells were split into fresh 10 cm2 
plate containing complete medium. Alternatively, cells can be counted using a 
hemocytometer and diluted to desired density. 
 
10.3  Quantification of cell number and viability with hemocytometer and  
trypan bleu staining 
To perform accurate quantification and to standardise culture conditions, it is 
necessary to determine the cell number. The hemocytometer was the instrument 
used in this work to determine the cell number. 
The hemocytometer consists of 4 corner squares, which are divided into 16 tertiary 
squares. Cells in the four corner squares were counted, and the number of cells per 
ml was determined according to the following equation: 
Cells/ml= average count per square x dilution factor x104  
(Each square is 1 m2 and the depth is 0,1 mm)  
The number of total cells was counted as follows: 
Total cells= cells/ml x the volume of cell suspension from which sample were taken 
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To determine the viability, cells were stained with trypan blue, 20 l of cells 
suspension was mixed with 20 l trypan blue for 1 min at RT before starting the 
counting. The principle of this technique is based on the ability of dying cells to 
uptake trypan blue, whereas the membrane of living cells is not permeable to trypan 
blue. 
 
The number of living cells was counted as follows: 
 
 
 
10.4  Preservation of cell lines 
10.4.1 Freezing  
For long-term storage cells have to be frozen. FCS was used in combination with 10 
% DMSO to store cells at –80°C or lower. The use of DMSO as cryoprotective agent 
is required to preserve cells, to reduce the freezing point and to allow a slower 
cooling rate. Gradual freezing is necessary to reduce the risk of ice crystal formation 
and cell damage. 
For Freezing, cells were treated according to 4.1.2. After trypsinisation and 
centrifugation for 5 min at 800 rpm, the pellet was resuspended in freezing medium to 
obtain 1x106 cells/ml. 1 ml aliquots of suspension cells was pipetted into labeled 
freezing tubes. Covering the tubes with towels allows a slower freezing at –80°C. 
  
10.4.2 Thawing 
Cells were removed from frozen storage and quickly thawed in a 37°C water bath. 
After thawing, the cell suspension was placed into a 10 cm2 plate containing 8 ml 
warm medium. The medium was changed in the next day to remove all traces of 
DMSO.  
% viable cells= 
Number of unstained cells 
Total number of cells x 100 
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10.5  Preventing mycoplasma contamination 
Mycoplasmas are small intracellular bacteria, which are difficult to detect visually in 
cultures. They multiply rapidly and affect cultures by interfering with cell metabolism, 
growth and eventually lead to cell death. 
Several direct and indirect methods are available in detecting mycoplasma in cell 
cultures, which differ in specificity, sensitivity and time requirements. PCR analysis 
using primers, which amplify specifically and selectively a part of the mycoplasma 
DNA was a very sensitive methods used during this work. 
To test cultures for the mycoplamsa contamination, cells were cultured for 1 week in 
plate without changing the medium. After scraping, 1 ml cells in suspension was 
pelleted for 30 min at 13000 rpm and resuspended in 100 l proteinase K buffer 
containing proteinase K. The sample was incubated for 90 min at 56°C followed by 3 
min at 95°C. After short centrifugation, the sample can be stored at – 20°C until 
testing by PCR, which was done kindly by Uta and Mona. 
To treat mycoplasma contamination antibiotics like ciprobay and BM cycline were 
used. This method is based on cultivation of contaminated cells in the presence of 
antibiotics and retesting them after removal of antibiotics. Disposal of contaminated 
culture, aseptic techniques and thawing of clean cells were the effective methods 
followed in this work to reduce, to prevent mycoplasma contamination, and to avoid 
antibiotics resistance due to a prolonged use of antibiotics. The cells used in this 
work were tested and confirmed to be free from mycoplasma contamination. 
 
10.6  Regulation of genes expression of genes expression by  
transfection 
10.6.1 Downregulation of gene expression using RNAi 
RNA interference (RNAi) is a molecular method to study the loss of gene function. 
Silencing target genes can be performed by the introduction of small interfering RNA 
(siRNA) to the cytoplasm resulting in the degradation of messenger RNA. siRNA 
consists of 19-21bp double-stranded RNA with 2-4 nucleotide overhang at the 3’ 
ends. One of the strands (the sense strand) is homologous to an area in the mRNA 
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of the target gene. To evaluate non-specific or toxic effects of the siRNA used, it is 
essential to include control siRNA unrelated to the target mRNA in all experiments. 
The transfection is achieved by the use of transfection reagents. HiPerFect was the 
transfection reagent used in this work. HiPerFect is a cationic lipid. si RNA 
complexed with the transfection reagent is efficiently released to the cells. 
Prior to the day of transfection, 0,9 x 10 5 cells were seeded into each well of a 6 
wells plate. The transfection mix, composed of siRNA in a final concentration of 5 nM 
mixed with 100 l serum free medium and with 6 l HiPerFect, was incubated for 10 
min and added dropwise to the cells. The analysis of gene silencing was carried out 
24-48 hrs after transfection by western blot. 
 
10.6.2 Transient gene expression 
Polyethylenimine (PEI) was the transfection reagent used for all transient 
transfections performed during this work. PEI has the capacity to condense DNA and 
allow its entry into cells by adsorptive endocytosis. 
1 x 106 Cells were seeded one day before transfection. A transfection mixture 
composed of plasmids, 800 l serum free and 20 l PEI was prepared and mixed. 12 
ug and 6 ug were the total amount of plasmids used for transfecting cells seeded in 
10 cm2 and in 6 cm2 plate, respectively. The transfection mixture was incubated for 
10 min at RT and added dropwise to the cells. 
The pH of the PEI used was optimised for each cell line. The PEI used for HeLa was 
pH 7,5, whereas HEK293 was transfected with PEI pH 6,45. 
48 hrs pre-transfection, the cells were harvested and analysed. 
 
10.7  Flow cytometry 
For flow cytometry analysis, cells were scraped and harvested by centrifugation at 
800 rpm for 5 min. The resulting pellet was resuspended in cold PBS and pelleted 
again. After removal of PBS, the cells were fixed with 4 ml 70 % cold ethanol, which 
was added dropwise to the pellet under vortex. The cells can be fixed either for 1 h at 
-20°C or overnight at 4°C. Cells can be stored at 4°C until further analysis. 
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Before analysis, the fixed cells were washed with PBS and pelleted by centrifugation 
at 800 rpm for 5 min. The resulting pellet was resuspended in freshly prepared DNA 
staining solution containing 10 g/ml propidium-iodide and 25 g/ml RNase A in PBS. 
The cells were resuspended in a volume required to obtain 1x106 cells/ml and 
incubated in dark at 37°C for 30 min. The FACS machine from BD Bioscience was 
used to perform the analysis and FlowJo OSX was the software used for data 
analysis. 
10.8  Quantification of apoptotic cells with annexin staining 
 
 Exposure of the membrane phospholipid phosphatidylserine (PS) to the outer leaflet 
of the plasma membrane is an early event of cells undergoing apoptosis.  
Annexin V is a 35-36 kDa Ca2+dependent phospholipid-binding protein that has a 
high affinity for the PS and binds to cells with exposed PS. Conjugated to 
fluorochromes including FITC, annexin can serves as sensitive probe for flow 
cytometry analysis of cells undergoing apoptosis. In combination with a vital dye such 
propidium iodide, it is possible to distinguish between early and late stage of 
apoptosis. At late stage, the cells lose the membrane integrity and are positive for 
annexin and PI. 
Apoptosis can be quantified either by fluorescence microscopy or by flow cytometry. 
For microscopy analysis, the cells were incubated for 15 min at 37°C with 5 l of 
annexin V alexa Fluor ® conjugates after inducing apoptosis. For flow cytometry, 
adherent and floating cells were collected and pelleted at 800 rpm for 5 min. The 
resulting pellet was resuspended in annexin binding buffer to get 1x106 cells/ml. 100 
l of cell suspension were incubated in the dark with 5 l annexin and 2 l PI (50 
ug/ml) for 15 min at RT. 400 l of annexin binding buffer were added to the cells, 
which were incubated on ice for an additional 15 min. The analysis was carried out by 
flow cytometry within the next 1 hr. 
11. Analytical cell culture techniques 
11.1  Cell lysis 
The cells were subcultured according to 4-1-2 in 10 cm2 plate and harvested by 
centrifugation at 800 rpm for 5 min.  The resulting pellet can be either stored at –
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20°C until use or directly lysed in RIPA-buffer containing protease and phosphatase 
inhibitors. The lysate was incubated on ice for 15 min, then sonicated twice for 20 s 
and centrifuged at 13000 rpm for 15 min at 4°C. The cell lysate was placed into a 
fresh tube and then used for immunoprecipitation therefore protein concentration was 
determined. 
11.2  Protein quantification using DC protein assay 
The concentration of a solubilised protein was determined using BCA protein assay 
kit following manufacturer’s instruction. The adsorption was measured at 650-750 nm 
with a microplate reader. The protein concentration was calculated via a standard 
curve. For generating the standard curve, 4 concentrations of BSA were prepared in 
RIPA buffer ranging from 0,2 g/ml to 1,2 g/ml. 
The lysates can be stored at –20°C until use or can be diluted in 25 % 4XSB and 
boiled for 5 min at 95°C for further protein analysis. 
11.3  Immunoprecipitation 
Selective immunoprecipitation of proteins is a useful tool for characterising proteins 
and protein-protein interaction. 
Immunoprecipitations consist of 3 steps; lysing the cell, binding of the proteins to the 
antibody, and precipitation of the immunocomplexe through binding of the antibody to 
either A or G beads depending on the antibody used.   
In this work, the cells were lysed in NP-40 buffer (3-6-4). After protein quantification 
(4-2-2), 0,5 mg lysates were incubated for 2 hrs at 4°C with the 2 g/ml specific 
antibody in a total volume of 500 l with rotation. Controls antibodies were also 
included at the same concentration as the specific antibody used for 
immunoprecipitation. In order to precipitate the protein-antibody complex, the lysate 
was incubated with 30 l G beads at 4°C with rotation. The beads were prewashed 
once with water and twice with NP40-buffer. After 1 hr incubation, the beads were 
recovered by centrifugation at 4°C and 800 rpm for 1 min, washed 5 times with NP40 
(3-6-4) and boiled at 95°C in 40 l 2XSB (3-6-4) for 5 min. Input (1/30 of the 
resulting) and immunoprecipitated complexe were resolved by SDS-PAGE and 
detected by western blotting using specific antibodies. 
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11.4  In Vivo ubiquitination assays 
This assay allows the detection of protein-His-ubiquitin adducts generated in cells 
after overexpression of protein of interest with His-Ubiquitin, which will be enriched 
on talon beads due to the histidine tag. A higher mobility forms of the protein of 
interest is detected by immunoblotting due to the addition of His-Ubiquitin. 
 HEK293 cells were seeded and transfected in the next day according to 4-1-5-2. For 
the entire experiment, HEK293 cells were transiently co-transfected with 3 g His-
Ubiquitin and expressing vectors encoding the tested interacting partners. 48 hrs 
post-transfection, cells were treated with 25 M MG-132 for 3 hrs in order to inhibit 
the proteasome. Cells were then washed with PBS, lysed in urea buffer (3-6-4), and 
sonicated 2 times for 20 S. Cells debris were removed by centrifugation at 13000 rpm 
and 4°C for 15 min. The lysate was transferred to new eppendorf tube. 60 l lysate 
from each sample served as input. The input samples were mixed with 20 l 4xSB 
and boiled for 5 min at 95°C. The rest of the resulting lysates was incubated with 30 
l Ni2+ talon beads (prewashed once with ddH2O and 2 times with urea buffer). The 
incubation was performed at RT for 2 hrs on a rotating wheel. Afterward the beads 
were washed 4 times with 1 ml urea buffer. After removing all traces of urea buffer, 
proteins were eluted from the talon beads by adding 40 l 2XSB containing 200 mM 
imidazole and boiled for 5 min at 95°C. Imidazole displaces His-ubiquitin bound 
proteins by competing for binding to the nickel ions in the talon beads. 
The ubiquitination of the desired proteins was analysed after SDS-PAGE separation 
and incubation with the appropriate antibodies. 
11.5  Protein separation by SDS- Page 
Discontinuous gel electrophoresis is a technique to separate proteins under 
denaturing conditions (in the presence of SDS) according to the molecular size. The 
proteins migrate through pores in the polyacrylamide gel matrix in response to an 
electrical field. The migration rate of the protein depends on the combination of pore 
size and protein charge, size and shape. The pore size increases with decreasing 
acrylamide concentration.  
In this system two sequential gels are used; the separating gel topped by the 
stacking gel. The stacking gel is acid (pH 6,8) and has a low polyacrylamide 
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concentration (5,5 %). In this conditions the proteins are poorly separated but form a 
thin bands, which get separated during migration though the separating gel (more 
basic pH 8,8 with a higher polyacrylamide content). 
The desired percentage of acrylamide in the separating gel depends on the size of 
the protein being separated. Generally 7,5 % gels is used for separation of SDS-
denatured protein with a size ranging from 60-200 kDa, 10 % gels for SDS-denatured 
proteins up to 70 kDa and 15 % gel for small proteins (12-45 kDa) (3-6-4 table 2 and 
3). 
The glass-plate sandwich of the electrophoresis apparatus was assembled according 
to the manufacturer’s instructions. The separating gel solution was poured 
immediately to the glass-plate sandwich. The top of the gel was covered with a layer 
of ethanol to allow polymerisation and guarantee the formation of a straight surface. 
The alcohol layer was removed after the gel formation. The stacking gel solution was 
poured to the glass-plate sandwich. The desired comb was used and removed from 
the stacking gel after polymerisation. The gel sandwich was attached to the upper 
chamber and placed to the lower buffer chamber. Both chambers were filled with the 
appropriate volume of running buffer. 
Protein samples containing 1X SB at a final concentration were denatured by boiling 
at 95°C for 5 min and applied to the gel wells. A protein-molecular-weight marker was 
used as a control during separation. The proteins migrate at 70 V thought the 
stacking gel. The voltage was increased to 100 V when the samples reach the 
separating gel.  
The electrophoresis should be stopped as the molecular weight marker shows the 
desired separation. The gel can be stained with comassaie blue or transferred to a 
membrane for immunoblotting. 
11.6  Western blot 
Western blot or immunoblotting is the method used to transfer the proteins separated 
by SDS-PAGE from the gel to the membrane. 
After finishing the electrophoresis, diassembling the gel sandwich and removing the 
stacking gel, the gel was equilibrated at RT in transfer buffer. 
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For the transfer, a nitrocellulose membrane was used. The membrane has to be first 
activated by a short incubation with 100 % methanol and rinsed with transfer buffer 
before proceeding to blotting. 
The gel, topped by the membrane, was placed to the blotting cassettes according to 
the manufacturer. Transfers for 1 hr at 100 V and 0,35 mA was generally sufficient. 
For overnight transfer, a current of 30 V and 0,09 mA was required. 
After the transfer, the membrane was removed from the transfer stack and the 
transfer efficiency was monitored with ponceau staining.  After washing with TNT, the 
membrane was blocked in TNT containing 5 % non-fat milk for 15 min at RT with 
constant agitation. Blocking the blotted membrane reduces non-specific binding of 
the antibody. Following blocking, the blots were washed in TNT and incubated with 
the primary antibody overnight. In the next day unbound antibody was removed by 
washing 3 times for 10 min in TNT. The blots were incubated with HRP-conjugated 
secondary antibody for 1 hr at RT and washed 3 times for 10 min in TNT. The 
primary and secondary antibodies for the immunoblots used in this work were diluted 
to the desired working concentration in TNT and are listed in table 4 and 5 (3-7-1). 
The protein detection was performed using ECL solution (3-6-4). This solution was 
prepared by mixing solution 1 and 2, followed by incubation for 5 min. The membrane 
was incubated for 1 min in ECl solution. In this system, HRP linked to secondary 
antibody catalyses in the presence of H2O2 the oxidation of luminol, which produces a 
chemiluminescence. The luminescence is enhanced by the addition of cumaric acid. 
The excess of the solution was removed and the blots were placed in a plastic bag. 
After smoothing out air bubbles, the wrapped membrane was placed in a film 
cassette. The film was exposed in dark until getting the appropriate signals and 
developed. 
11.7  Determination of protein half-lifes 
Half-life experiments allow the analysis of protein stability. In this work, the analysis 
was performed after inhibiting the protein synthesis by 25 g/ml cycloheximide added 
to the cells in the day of the experiment. After addition of cycloheximide, cells were 
pelleted at different time points for protein extraction using RIPA buffer. Alternatively, 
the cells can also be scraped in 200 l 2XSB, sonicated and boiled for 5 min at 95°C. 
The proteins were separated by SDS-PAGE. 
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11.8 Immunostaining 
For immunofluoresence, cells were seeded in 10 cm2 plates containing coverslips 
and placed in a
 
humidified incubator at 37°C and 5 % CO2. After 24-48 hrs, cells 
grown on coverslips were washed twice with PBS, fixed in 4 % PFA for 20 min, 
permeabilised for 2 min with 0,2 % triton X-100 in PBS and then blocked with PBS 
containing 2 % BSA for 1 hr at RT. After washing with PBS, cells were incubated in 
the dark with primary antibody either for 1 hr at 37°C or overnight at 4°C according to 
the manufacturer recommendations. After incubation with primary antibody, the cells 
were washed 3 times with PBS and then incubated in the dark with fluorescence-
conjugated secondary antibody at 37°C for 1 hr. The antibody dilution was prepared 
in the blocking buffer. Table 4 summarizes the required dilutions for all the antibodies 
used in this work. To visualise the nuclei, cells were co-stained with DAPI for 1 min. 
After washing cells with H2O, the cover-slips were mounted onto glass slides. 
ProLong gold antifade from invitrogen was the mounting medium used in this work. 
The analysis was performed directly under fluorescence microscopy. Alternatively, 
coated coverslips can be stored for several days in the dark at 4°C until analysis. 
12. Molecular biological method 
12.1  RNA analyses 
12.1.1 RNA extraction 
The RNA was isolated by acid guanidinium thiocyanate-phenol-chloroform extraction. 
For the RNA extraction, cells were pelleted by centrifugation and resuspended in 500 
l solution D. The resuspended pellet can be either stored at -80°C or directly used 
for the RNA isolation. 
50 l of 2 M Na-acetat pH4 was added to the resuspended pellet. In order to 
dissociate proteins from DNA, 500 l phenol was added. After vortexing, 100 l 
chloroform was added. Chloroform denatures proteins and lipids and helps in 
separating nucleic acid from proteins. The resuspended pellet was incubated for 15 
min on ice and subjected to a 5 min centrifugation at 4°C and 10000 rpm. The 
centrifugation allows the separation of two phases. The upper phase was transferred 
to a new eppendorf and extracted for a second time with 400 l chloroform. After 
centrifugation for 5 min at 4°C and 10000 rpm, the supernatant containing RNA was 
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transferred to new eppendorf and precipitated with 1 volume of 100 % isopropanol for 
90 min at -20°C. After spinning for 10 min at 4 °C and 10000 rpm the pellet was 
washed with 70 % ethanol. The pellet was shortly air-dried and solved in 10-30 l 
DEPC H2O. The RNA concentration was quantified using a photometer.  
The RNA can be either stored at - 80°C or directly used for the synthesis of the 
complementary DNA (cDNA) for the RT-PCR.  
 
12.1.2 cDNA synthesis 
cDNA or complementary DNA is synthesised in vitro from RNA using a reverse 
transcriptase. The cDNA can be used for RT-PCR for expression analysis. For the 
synthesis, 1-2 g of RNA were used depending on the RNA concentration obtained 
after extraction. The synthesis was carried out with a kit from BioRAD according to 
the manufacturer instructions.  
12.2  DNA analyses 
12.2.1 Polymerase chain reaction (PCR) 
Polymerase chain reaction is a technique used in molecular biology to amplify 
specific DNA. The selectivity of PCR results from the use of primers that are 
complementary to the DNA region targeted for amplification. PCR is based on the 
repetition of the cycle composed of 3 reactions; the first one is a denaturing step, 
which allows the separation of the double-stranded DNA. It is followed by an 
annealing reaction, in which the primers bind to complementary base on the single 
stranded DNA. In the third reaction the DNA is synthesised by the polymerase.  
Parameters of each step (time and temperature) were optimised according to the size 
of target DNA fragment and annealing temperature used for amplification.  
For the RT-PCR, the mastermix was prepared as follows: 
17,5 l MilliQ 
2,5 l 10x ThermoPol Reaction Buffer  
1 l Primer A 
1 l Primer B  
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1 l dNTP’s 
1 l TAQ polymerase 
24 l reaction 
The 24 l master mix were added to 2 l of the synthesised cDNA in 4-3-1-2. After 
vortexing, the PCR reaction was started according to the next program: 
Standard program: 
    Lid on 110°C 
    94°C    3'                 DNA Denaturing 
    94 °C    30'  DNA Denaturing 
    x   °C    30'  Primer Annealing    25 - 30x 
    72 °C    30'  Strand Elongation 
                                         72 °C    10'           Final Elongation 
 
 
The PCR product can be analysed using agarose gel electrophoresis. 
 
12.2.2  Agarose electrophoresis  
Gel electrophoresis is a technique used to separate nucleic acids according to the 
length of the molecules in an electrical field. 
The agarose was dissolved to the desired concentration in 1X TBE, heated to boiling 
in a microwave and supplemented with 0,5 g/ml ethidium. The concentration of the 
agarose gel varies according to the size of amplified DNA. Low agarose 
concentrations are used to separate large DNA fragment, whereas separation of 
small DNA molecules required less agarose concentration. 
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For the RT-PCR product, 1/10 volume of 10Xagarose loading buffer was added to 
the PCR master mix and pipetted into the well of the agarose gel. Inclusion of DNA 
marker on the gel allows the identification of the fragment depending on its size. 
After completing the electrophoresis, the gel can be visualised on a UV 
transilluminator. 
Agarose electrophoresis was also used to analyse the size of the DNA following 
restriction enzyme digest.  
12.2.3 Restriction enzyme digestion 
Restriction digest allows the cleavage of DNA at specific sites termed restriction sites 
using the respective restriction enzyme.  
Analytical restriction digest was performed for 1-2 hrs at 37°C. 
1-2 g DNA Plasmid/PCR product 
2 l 10x restriction digest buffer (1/10th total volume) 
1/100 of 100 x BSA if required for one of the enzymes 
0.5-1 l enzyme 1  
0.5-1 l enzyme 2 
x l ddH2O (autoclaved) 
20 l reaction 
 
12.3  Cloning 
Full length and fragment of Gadd34 were cloned to the expression vector pCS+HA. 
Therefore appropriate primers were designed. 5’ EcoRI and 3’ Xho restriction sites 
were included to the designed primers. pCS+HA-N1, pCS+HA-N2 and pCS+HA-
N3 encode the part of Gadd34 located between 117-674 aa, 162-674 aa and 483-
674 aa respectively.The full length Gadd34, N1, N2 and N3 were amplified from 
Gadd34pCMV by PCR and cloned into 5’ EcoRI and 3’ Xho sites of pCS+HA vector. 
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Table 9 summarises the list of primers used for the cloning. The PCR amplification 
was performed using Pfu polymerase and was carried out for 25 cycles.  
Following PCR, the genetrated products and the vector were digested with EcoRI 
and Xho. The restriction digest was performed as described in 4-3-2-3. The 
generated fragments were ligated to pCS+HA (4-3-3-2) after elution from the agarose 
gel (4-3-3-1). 
 
12.3.1 DNA elution from agarose gel  
A 0,8 % preparative agarose gel was used after restriction digest for the separation 
of the fragment required for cloning from other fragment. After completing the gel 
electrophoresis the DNA bands were visualised under UV and respective bands were 
cut from the gel and subjected to elution using an extraction Kit. In this work, ex-gel – 
OLS kit was used and the extraction was carried out according to the manufacture 
instruction.   
The relative amount of the vector and insert was estimated after extraction by running 
a few l on an analytical agarose gel (usually 0.8-1 %). 
 
12.3.2 Ligation 
This technique allows the covalent linking of two ends of DNA molecule using DNA 
ligase, which catalyses the formation of phosphodiester bonds between juxtaposed 5’ 
phosphate and 3’ hydroxyl terminus of double stand DNA. The T4 DNA ligase was 
the ligase used in this work. 
 
Ligation               Control reaction 
100 ng Vector      100 ng Vector 
x ng insert (see above)            - 
2 l 10x ligation buffer              2 l 10x ligation buffer 
0.5 l ligase T4 (10U; NEB, Fermentas)  0.5 l ligase (10U; NEB)                                                                            
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y l ddH2O (autoclaved)               z l ddH2O (autoclaved) 
20 l                   20 l 
 
The reaction was carried out at RT for more than 1 hr.  
 
12.3.3 DNA precipitation 
Ethanol precipitation is the technique used for concentrating nucleic acid in aqueous 
solution. In this technique salt and ethanol are added to the aqueous solution, which 
forces the nucleic acid to precipitate out of solution. 
PCR products or DNA after restriction digest were precipitated with this method. To 
this end, 1/10 volume of 3 M sodium acetate (pH 5,2) was added to the sample and 
mixed properly. For the precipitation 2,5 volume of 100 % ethanol was used and the 
precipitation was carried for 1 hr at –20°C. The precipitated nucleic acid was 
separated from the rest of the solution by centrifugation. The pellet was washed in 
cold 70 % ethanol and pelleted by centrifugation. The nucleic acid pellet was air dried 
and resuspended in the appropriate volume of TE or water. 
 
12.4  Plasmid preparation 
12.4.1 Transformation 
Transformation of electrocompetent bacteria was achieved in this work using 
electroporation. This technique allows the entry of DNA apparently through hole in 
the cell membrane produced by a high-voltage electrical field applied briefly to the 
competent cells. Freshly prepared cells or frozen one can be used for the 
transformation. In the case of frozen cells it is required to allow the bacteria to cool 
down first on ice, 50-100 ul electrocompetent cells (prepared by sangita) were used 
for the electroporation. 1 g of DNA (or 5 l of ligation reaction) was added to the 
bacteria and mixed gently. The mixture DNA/bacteria was pippted into 
electroporation cuvettes, which were already pre-cooled on ice. A BioRAD-
electroporator was used for the electroporation of bacteria, which were transferred 
back to the ice after the electrical shock. The bacteria were transferred carefully to 1 
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ml of 1XLB medium and incubated at 37°C under shaking either for 1h or for 30 min. 
To select for the transformed bacteria, 100 l and 900 l of the bacterial suspension 
were plated on LB with antibiotics and incubated at 37°C overnight. 
Clones were picked and the DNA can be analysed after extraction. 
  
12.4.2 Minipreps of plasmid DNA 
The isolation of small amount of DNA from bacteria was performed using the alkaline 
lysis. The method consists of 4 steps; in the first one the bacteria are resuspended in 
a solution A (3-6-3). In the second step, the cells are lysed with solution B containing 
NaOH and SDS (3-6-3). SDS leads to lysis and release of the cell contents through 
solubilisation of the cell membrane. NaOH denatures proteins and chromosomal 
converting thereby the double-stranded DNA in the cell to single stranded DNA. The 
addition of potassium acetate in the third step allows the neutralization of the lysate, 
the re-naturation of the plasmid and the precipitation of SDS taking protein, lipids and 
chromosomal DNA. In the last step the plasmid DNA can be concentrated using the 
ethanol precipitation for example. 
Prior the day of DNA extraction, 5 ml of 1XLB media (containing the required 
antibiotic) was inoculated with the tested clones. After 16 hrs (time to get sufficient 
growth), 1,5 ml of cells were pelleted by centrifugation at 6000g. The pellet was 
resuspended in 100 l solution A (containing a tiny amount of lysozyme). 200 ul of 
solution B (3-6-3) was added to the resuspended pellet and mixed gently but 
thoroughly by inverting.  5 min incubation on ice allows maximum release of the 
plasmid DNA from the cells. For the neutralisation 150 l of buffer C was added 
followed by 5-10 min incubation on ice. A 10 min centrifugation at 13000 rpm and RT 
enhances the precipitation of debris. For the precipitation of the plasmid DNA, the 
supernatant was transferred into new eppendorf containing 850 l of 100 % ethanol, 
mixed and incubated for 15 min at –20°C. After a centrifugation at 4°C and 13000 
rpm for 15 min, the DNA pellet was washed with 70 % ethanol and pelleted again by 
centrifugation.  The pellet was dried for 5 min and dissolved in 20-50 l TE containing 
20 ug/ml of RNase. 
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12.4.3 Large-scale preparation of plasmid DNA: CsCl2 
Isolation of DNA using cesium chloride gradient centrifugation allows the isolation of 
large-scale of clean plasmid DNA. In this method, DNA isolation by the alkaline lysis 
procedure is followed by equilibrium ultracentrifugation in cesium chloride-ethidium 
bromide gradients. The difference in the density enables the separation between the 
genomic DNA and plasmid DNA. 
An overnight culture was prepared by inoculating 5 ml 1XLB medium with bacteria 
containing the desired plasmid. In the next day, 200 ml of 1XLB medium 
supplemented with the appropriate antibiotic was inoculated with 200 l from the 
prepared overnight culture.  
After harvesting the bacteria containing the desired plasmid by centrifugation for 20 
min at 4°C and 4000 rpm, the pellet can be stored at -20°C or directly resuspended in 
12 ml solution A (3-6-3) by pipetting up and down. Lysis buffer (prepared fresh) was 
added to the sample, mixed by inverting and incubated for 5 min at RT. 18 ml 
solution C (3-6-3) was added to the lysate, which was incubated for 20 min on ice 
and pelleted by centrifugation for 20 min at 4°C and 40000 rpm. The centrifugation 
allows the precipitation of detergent solubilised proteins and membranes with sodium 
acetate. The supernatant was then cleared by filtration.  
The DNA-containing supernatant was transferred into a new tube, and the plasmid 
was precipitated by the addition of 40 ml of a 100 % isopropanol. After 20 min 
centrifugation at 4°C at 4000 rpm, the pellet was resuspended in a 10 ml TE buffer 
(3-6-3) pH 8,0. 2 ml of 10 M ammonium acetate was added to the resuspended 
pellet. After 20 min incubation on ice, a centrifugation for 20 min at 4°C and 40000 
rpm allows the separation the rest of proteins and DNA.   
The precipitation of the DNA-containing supernatant was achieved by addition of 32 
ml of 100 % Ethanol followed by a centrifugation at 4°C and 4000 rpm for 20 min. 
The DNA pellet was air-dried shortly and resuspended in TE pH 8,0. 4,71 g of cesium 
chloride was dissolved in the DNA in suspension. 200 ul ethidium bromid and 51 ul 
triton 100X were added to the cesium chloride/DNA. 
After a centrifugation for 10 min at RT and 4000 rpm, the samples were transferred 
into a Beckman Coulter ultra centrifuge tube and the tube were filled up to the neck 
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with TE buffer. Precautions to avoid air bubble were necessary. After sealing, the 
balanced tubes were placed in the rotor and the samples were subjected to 
ultracentrifugation overnight at 22°C and 50000 rpm. 
In the next day, two-ethidium bromide stained bands were visible. The lower Band 
(plasmid DNA) visualised under long wave UV light was carefully removed using a 
needle and a syringe and transferred to a 15 ml falcon. 
Separation of the DNA from the ethidium bromide was achieved through extraction 
with an equal volume of 5 M NaCL saturated isopropanol. After inverting, the upper 
phase containing ethidium bromid was removed. The extraction was repeated 
several times until no trace of ethidium bromide was detectable in both phases.  
In order to precipitate DNA, 2 volume of ddH2O and 2,5 volume of 100 % ethanol was 
added to the solubilised DNA. The precipitation was performed at -20° for 1 hr. The 
precipitated DNA was pelleted by precipitation by centrifugation for 20 min at 4°C and 
4000 rpm. The DNA was washed with 70 % Ethanol, dried and resuspended in 300-
500 l TE buffer pH 8,0.  
In the next day, the concentration and the purity of DNA were assessed using 
photometer by measuring the absorbance generated at 2 wavelengths (260-280 nm). 
The plasmid DNA was assayed by restriction digestion and detected on agarose gel 
electrophoresis. The DNA should be stored at 4°C. 
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IV. Results 
1. Analysis of the interaction between overexpressed Gadd34 
and Cdh1 
1.1 Gadd34 interacts with Cdh1 in yeast and in mammalian cells 
 
In order to define new interacting partner for the cell cycle regulator Cdh1, Dr. 
Kristine Bousset performed a yeast-two-hybrid screen with the full length human 
Cdh1. In this screen, she succeeded to identify Gadd34 interacting with Cdh1. 
 
To examine whether Gadd34 and Cdh1 also interact in mammalian cells, co-
immunoprecipitation assays were performed. HeLa cells were transfected with 
plasmids expressing Mt-Cdh1 and Gadd34 either separately or in combination. Cell 
lysates were subjected to immunoprecipitation either with Gadd34 or with 9E10 
antibody. To confirm the specific interaction between the immunoprecipitated proteins 
and the used antibodies, lysates were also immunoprecipitated with control 
antibodies. An actin antibody and normal rabbit IgG were the controls for the 9E10 
and the Gadd34 antibody respectively. 1/30 of the lysates served as input. 
 
The immuno and co-immunoprecipitated proteins were collected with protein G 
beads and detected by immunoblotting using Gadd34 and Cdh1 antibodies.  
 
Immunoprecipitation using the 9E10 antibody shows that it was possible to bring 
Gadd34 down only when MT-CDH1 and GADD34 were cotransfected. The 
interaction was specific as no immunoprecipitated proteins were detected after 
immunoprecipitation using an actin antibody (Fig 9A).  
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Mt-Cdh1 was also specifically co-immunoprecipitated with the Gadd34 antibody but 
not with rabbit IgG. The co-immunoprecipitation was only observed when Gadd34 
and Mt-Cdh1 were coexpressed (Fig 9B). 
In agreement with the first Co-immunoprecipitation assays performed by Dr. Bousset, 
these results demonstrate the specific interaction between Gadd34 and Cdh1 in 
mammalian cells after overexpression of these proteins. 
 
 
 
 
Fig. 9: Gadd34 interacts with Cdh1 in yeasts and mammals 
 
A, B HeLa cells were transfected with 1 ug GADD34 and 1 µg MT-CDH1 separately or in combination. 
Lysates were immunoprecipitated with the anti-9E10 antibody (Fig 9A) and with anti-Gadd34 (Fig 9B). 
Control antibodies were used at the same concentration as the specific antibodies. 
Immunoprecipitation was followed by western blotting and detection with antibodies against 9E10 and 
Gadd34. 1/30 of cell lysates was used as input. 
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1.2 The C-terminal region of Gadd34 is sufficient for Cdh1 interaction 
 
 
 
The APC/CCdh1 substrates are characterised by the presence of D-Box (RXXL) and/or 
KEN-Box. Sequence analysis of human GADD34 revealed the absence of a KEN box 
and the existence of 5 RXXL motifs; one located at position 93-96 conserved 
between rat, mouse and human and 4 D-Boxes located at position 65-68, 139-142, 
296-299 and 526-529 aa (Fig 10). 
To determine the part of Gadd34 recognised by the APC/CCdh1, 3 deletion mutants 
were generated by PCR using the corresponding primers incorporating the 
appropriate restriction sites. The full length GADD34 and the 3 generated constructs 
(N1 (117-674 aa), N2 (162-674 aa), and N3 (483-674 aa)) were subcloned into 
pCS2+ vector containing an HA-tag sequence (Fig 10).  
 
 
Fig. 10: Generation of deletion mutants 
 
N1 (117-674 aa), N2 (162-674 aa) and N3 (483-674 aa) constructs were generated by PCR using 
the appropriate primers and confirmed by sequencing. The different constructs and the full length 
GADD34 were cloned into the pCS2+HA tag plasmid. N1 contains the D-Box located at position 139-
142 aa, 296-299 aa and 526-529 aa. The 3 first D-Boxes, located at position 65-68, 93-96 and 139-
142 aa, are absent in N2 deletion mutant. Whereas N3 contains only the D-Box located at position 
526-529 aa. 
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Co-immunoprecipitation assays were performed in order to analyse the interaction of 
Cdh1 with the 3 generated deletion mutants and full length Gadd34. HEK293 cells 
were transiently transfected with the 4 constructs either separately or in combination 
with MT-CDH1. Cell lysates were subjected to immunoprecipitation using either anti-
HA or anti-actin antibodies and Immunoprecipitates were analysed by immunoblotting 
using anti-HA and anti-9E10 antibodies (Fig 11).  
 
 
Fig. 11: Cdh1 interacts with C-terminal region of Gadd34 
 
HeK293 cells seeded in 10 cm2 plate were transfected with 1 µg plasmid expressing full length 
Gadd34 (3A), n1 (3B), n2 (3C) and n3 (4D) either separately or in combination with and 1 µg 
plasmid expressing Mt-Cdh1. Lysates were immunoprecipitated with anti-HA. An anti-actin antibody 
was used as a control. Immunoblotting was performed to detect immunoprecipitated HA- constructs 
and co-immunoprecipitated MT-Cdh1 using anti-HA and anti-9E10 antibodies, respectively. The 
asterics (*) point to unspecific Bands.  
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These Data show that n1, n2 and n3 were all able to interact with the 
overexpressed Cdh1. Cdh1 was only co-immunoprecipitated in the presence of either 
of these constructs. In addition, no immunoprecipitates were detected by using an 
actin antibody as unspecific control (Fig 11).  
The results suggest that the C-terminal region (483-674 aa) is the part of Gadd34, 
which interacts with Cdh1. This in agreement with the result of the two-hybrid screen, 
as the C-terminus of Gadd34 was the part found in the screen. 
 
1.3 Cdh1 can target Gadd34 for ubiquitination 
APC/CCdh1 is an E3 ligase in the ubiquitin pathway. To determine whether Cdh1 
targets Gadd34 for ubiquitination, His-ubiquitination assays were performed.  
 
Gadd34 was expressed in HEK293 cells in combination with His-ubiquitin and 
increasing levels of Mt-Cdh1. 48 hrs after transfection, the cells were treated for 3 hrs 
with MG-132 to accumulate polyubiquitinated proteins by inhibiting the proteasome 
and according to the scheme shown in figure 12A. 1/34 of the cell lysates served as 
input, whereas the rest of the cell lysates was incubated for 2 hrs with talon beads to 
bind the whole His-ubiquitin bound proteins. After SDS-PAGE, immunoblotting using 
anti-Gadd34 antibody was performed in order to detect the ubiquitinated Gadd34.  
    
The polyubiquitinated proteins migrate on the SDS-PAGE as a smear caused by the 
addition of His-Ubiquitin to the target protein (about 18-20 kDa per His-ubiquitin). 
  
Western blot analysis showed that overexpression of His-ubiquitin resulted in weak 
ubiquitination of Gadd34, which was strongly enhanced in after overexpressing 
CDH1 in a concentration dependent manner (Fig 12B).  
To further confirm the direct involvement of Cdh1 in the Gadd34 ubiquitination, 
specific inhibitors of the APC/CCdh1 activity were used. The Cdh1 inhibitor Emi 1 and 
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the N-terminal region of Cdh1 (N125), which acts as dominant negative, were 
cotransfected in combination with Cdh1 at two different levels (1 and 3 µg) (Fig 12C). 
 
 
 
Fig. 12: Gadd34 is getting ubiquitinated in a Cdh1-dependent manner 
 
 
A. Scheme describing the principle of the His-ubiquitination assay. B, 0,5 µg plasmid expressing 
Gadd34 was transfected into HEK293 cells, in combination with His-ubiquitin and increasing amounts 
of CDH1 plasmid (0,2, 1 and 2 µg). 2 days after transfection the cells were treated with MG132 for 3 
hrs. The lysates were incubated for 2 hrs with talon beads, separated by SDS-PAGE and subjected to 
immunobloting to detect the level of ubiquitinated Gadd34. B, To inhibit Cdh1, 1- 3 µg of Emi-1 and 
Cdh1- N125 were cotransfected with Mt-Cdh1, and the level of Gadd34 ubiquitination was analysed as 
before. 1/34 cell lysates was used as input. 
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Western blot analysis confirmed that overexpression of Cdh1 resulted in an increase 
in Gadd34 ubiquitination, which was slightly decreased after overexpressing Emi-1. 
Gadd34 ubiquitination was also clearly decreased after overexpression N-terminal 
Cdh1 and almost completely inhibited after increasing the level of overexpressed 
Cdh1 (N125). In addition, Cdh1 (N125) caused a reduction of Gadd34 ubiquitintion in 
the absence of overexpressed full length Cdh1 (Fig 12C). Analysis of the level of 
overexpressed proteins revealed a difference in the expression level between Mt-
Emi1 and Mt-Cdh1 (N125) (Fig 12C). 
The first His-ubiquitination assay performed by Dr. Jörg Vervoorts showed the same 
results as the presented data. 
Taken together, ovexpression of increasing levels of Cdh1 enhanced the 
ubiquitination of Gadd34. This ubiquitination decreased after overexpressing Cdh1 
inhibitors. Thus, Cdh1 was directly involved in the ubiquitination of Gadd34. 
 
2. Analysis of the interaction between Gadd34 and Cdh1 at the 
endogenous level 
2.1 Gadd34 is induced during the ER stress 
Physiological and pathological processes that affect protein folding can induce ER 
stress and thereby Gadd34. Tunicamycin, a specific inhibitor of N-glycolysation, and 
the proteaosome inhibitor MG-132 are well-known ER stress inducer and activator of 
the UPR. Treating HeLa cells with MG-132 (25 µM) for 3 hrs or incubation with 5 
µg/ml tunicamycin for 7 to 16 hrs resulted in an accumulation of Gadd34 (Fig 13A). 
 
Glucose deprivation was the first tool used to induce ER stress. The effect of glucose 
deprivation on HeLa cells concerning Gadd34 induction was examined after 
cultivating them for 24 hrs in medium lacking glucose. Western blot analysis revealed 
that depriving cells of glucose for 24 hrs resulted in the accumulation of Gadd34 (Fig 
13B). The effect of glucose deprivation was examined for different cell lines including 
HCT116, HEK293 cells and U20S by cultivating them for 24 hrs in the absence of 
glucose. Analysis of the Gadd34 level indicated that the induction of Gadd34 by 
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glucose deprivation was not only related to HeLa cells, but was also observed in 
HEK293, HCT116 and U20S (Fig 13B). 
  
Fig. 13: Gadd34 is induced in different cell lines during ER stress 
A. HeLa cells were treated either with MG-132 (25 µM) for 3 hrs or with Tunicamycin (5 µg/ml) for 7 
and 16 hrs, the Gadd34 levels were analysed by western blot. Actin was used as loading control. 
 B. HCT116, HEK293 cells U2OS and HeLa cells were cultivated in medium lacking glucose for 24 hrs 
and the levels of Gadd34 were analysed by western blot. Actin served as control for equal loading. 
 
To analyse the effect of glucose deprivation on HeLa cells in more detail time course 
experiments were carried out. 
HeLa cells were deprived of glucose for 0, 4, 8, 12, 16 and 20 hrs and the GADD34 
expression was examined at the transcriptional level by RT-PCR. The RNA was first 
extracted form samples taken at the indicated time points. cDNA synthesis was 
carried out. Two sets of primers were designed to detect a target sequence of 
Gadd34. The levels of Gadd34 mRNA were normalised to HPRT, which was used as 
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internal control in the RT-PCR. After semi semi-quantitative RT-PCR, GADD34 
transcripts was first seen after 8 hrs glucose deprivation (Fig 14). 
The Gadd34 protein levels and representative markers of the unfolded protein 
response such as eIF2, P-eIF2 and Chop were analysed as well by 
immunoblotting at the indicated time points (Fig 14).  
              
Fig. 14:  Glucose deprivation induces the activation of the ER stress response 
and the accumulation of Gadd34 
The figure shows a representative experiment performed in HeLa cells, which were cultivated in the 
absence of glucose to induce ER stress. GADD34 expression was analysed by RT-PCR and by 
western blot at the indicated time points. Cdh1 level and the level of important markers of ER stress 
were analysed by western blotting. HRTP was used as control for equal cDNA and actin for equal 
proteins loading. 
Western blot analysis indicated that Gadd34 protein started accumulating after 16 
hrs. In other experiment, Gadd34 was also detectable after 12 hrs glucose 
deprivation. The level of Chop (Gadd153) accumulated allways in parallel to Gadd34. 
eIF2 was highly phosphorylated after 8 hrs of glucose deprivation and became less 
phosphorylated later on (12 hrs after glucose deprivation). The level of Cdh1 was not 
affected during glucose deprivation (Fig 14). 
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2.2 Gadd34 levels decrease after releasing cells from stress 
To analyse the level of Gadd34 after removal of stress, HeLa cells were deprived of 
glucose for 16 hrs, then released in medium containing glucose according to the 
scheme shown in figure 15A. The level of Gadd34 was examined by western blot at 
the indicated time points (Fig 15B).      
                                                                                                                                                                            
           
Fig. 15: Gadd34 level decreases after releasing cells from ER stress 
      
                              
A: Scheme describing the experimental design by which GD for 16 hrs was used to induce ER stress, 
followed by cultivation in complete medium for recovery. B, HeLa cells were cultivated in medium 
without glucose for 16 hrs and released in complete medium. The level of Gadd34 and Cdh1 were 
analysed after 16 hrs glucose deprivation and within the release at the indicated time points by 
western blot. C, HCT116 were subjected to glucose deprivation for 16 hrs and released in medium 
containing glucose. The level of Gadd34 was analysed by western blotting. Actin was used as control 
for equal loading. The asterisks (*) point to unspecific bands. 
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The result shows that the level of Gadd34 decreased after releasing the cell from the 
stress to reach a very low level after 4 hrs growth in complete medium (Fig 15B). This 
indicates that accumulation of Gadd34 is reversible after removal of the stress (Fig 
15B). 
This reversibility was also analysed in HCT116. After 16 hrs cultivation in medium 
lacking glucose, HCT116 cells were released into complete medium and the levels of 
Gadd34 were examined by western blotting for the indicated time points (Fig 15C). 
As in HeLa cells, the level of Gadd34 also decreased to a low level after releasing 
HCT116 from ER stress (Fig 15C). 
2.3 Gadd34 is a protein with short half-life 
To determine the stability of Gadd34, half-life experiments were carried out. HeLa 
cells were deprived of glucose for 16 hrs to induce the ER stress. The total protein 
synthesis was inhibited by adding cycloheximide in a final concentration of 25 µg/ml. 
Samples were taken at the indicated time points to analyse remaining proteins by 
immunoblotting (Fig 16A). The level of Gadd34 declined rapidly to less than 50 % 
within 30 min after cycloheximide addition. Quantification of 3 independent 
experiments confirmed that Gadd34 is a short-lived protein with a half-life of less than 
30 min (Fig 16B). 
To test whether the stability of Gadd34 is dependent on the type of the ER stress 
inducer, HeLa cells were treated with 5 µg/ml tunicamycin for 16 hrs. After inhibiting 
the total protein synthesis, Gadd34 stability was analysed by western blotting. The 
result indicated that if the ER stress was induced by tunicamycin, Gadd34 is an 
unstable protein, too (Fig 16C).  
The turnover of Gadd34 was also examined in another cell line to analyse whether 
the instability of this protein is cell specific or not. Therefore, HCT116 cells were 
deprived of glucose for 16 hrs. The protein synthesis was inhibited by cycloheximide 
and the levels of Gadd34 were analysed for the indicated time points by western 
blotting (Fig 16D). The result confirmed that Gadd34 induced in HCT116 by glucose 
deprivation in is instable as shown in HeLa cells (Fig 16D). 
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Fig. 16: Gadd34 is a protein with short half-life 
A.Gadd34 stability was examined in HeLa cells subjected to 16 hrs glucose deprivation. The protein 
synthesis was inhibited by 25 µg/ml cycloheximide and the level of Gadd34 was analysed by 
immunoblotting. The graph in B represents the quantification of 3 independent experiments. Gadd34 
levels were normalised to actin. All values are expressed relative to the zero time point. B. Gadd34 
stability was analysed in tunicamycin-treated HeLa cells. D. Gadd34 stability was analysed in HCT116 
as it was performed in HeLa cells. Actin was used as a control for equal loading. 
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Taken together, these data suggest that Gadd34 induced during the ER stress is a 
protein with a short half-life (Fig 16A). An effect, which was seen by different inducers 
of ER stress (Fig 16C) and seen in 2 different cell lines subjected to ER stress (Fig 
16E). 
2.4 The absence of Cdh1 results in accumulation and stabilisation of  
Gadd34 
To understand the functional significance of the interaction between Gadd34 and 
Cdh1, it was important to know whether Cdh1 is involved in regulating Gadd34 
turnover under physiological conditions. Therefore, the level and the stability of 
Gadd34 were analysed in the presence and after depleting Cdh1 using specific si 
RNA targeting Cdh1. 
 
2.4.1 Gadd34 is slowly reduced in the absence of Cdh1 during recovery 
The level of Gadd34 was first examined in the presence and absence of Cdh1. 
Therefore, HeLa cells were transfected either with Cdh1 si RNA or control si RNA in 
a final concentration of 5 nM.  24-30 hrs after transfection, cells were first starved of 
glucose for 16 hrs and then release in complete medium (Fig 17A). The level of 
Gadd34 was analysed by immunoblotting before, after glucose deprivation and within 
the release from stress, according to the scheme in figure 17A. The Cdh1 depletion 
was also analysed by western blot (Fig 17B). 
Down regulation of Cdh1 resulted in a high accumulation of Gadd34 during stress 
and strongly inhibited the reduction of Gadd34 levels during the release (Fig 17B).  
 
Quantification of Gadd34 levels of 3 independent experiments showed that in the 
presence of Cdh1 the level of Gadd34 declined to about more then 50 % after 3 hrs 
release, whereas in the absence of Cdh1 the Gadd34 remained up more then 80 % 
detectable after 3 hrs release (Fig 17C). 
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Down regulation of Cdh1 resulted in a high accumulation of Gadd34 during stress 
and slower reduction of Gadd34 levels during the release (Fig 17B). 
 
Fig. 17: Silencing of Cdh1 results in a higher accumulation of Gadd34 during 
stress and a slower reduction during the release 
 
A. The scheme represents the experimental design by which the level of Gadd34 was analysed in the 
presence and absence of Cdh1. After transfecting HeLa cells either with Cdh1 si RNA or negative si 
RNA (5 nM), cells were subjected to glucose deprivation for 16 hrs and then released from stress in 
medium containing glucose. B. The level of Gadd34 and Cdh1 were analysed by immunoblotting after 
16 hrs glucose deprivation and within the release at the indicated time points. Actin served as control 
for equal loading. C, The graph represents the quantification of 3 independent experiments showing a 
slower reduction of Gadd34 levels during the release in cells depleted of Cdh1 compared to cells 
transfected with control si RNA. 
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2.4.2 Gadd34 becomes more stable in the absence of Cdh1 
In order to analyse whether the absence of Cdh1 might affect the stability of Gadd34, 
half-life experiments were carried out in the presence and after depleting Cdh1. HeLa 
cells were transfected either with Cdh1 si RNA or control si RNA and in the next day 
subjected to glucose deprivation for 16 hrs according to the scheme (Fig 18A). The 
levels of Gadd34 were assessed after inhibiting protein synthesis for the indicated 
time points by western blotting (Fig 18B). Quantification of Gadd34 level in three 
independent experiments show that the half-life of Gadd34 was extended from about 
1 hr in con si RNA transfected cells to about 4 hrs in cells depleted of Cdh1 (Fig 
18C). 
 
Fig. 18: Cdh1 regulates Gadd34 stability. 
The scheme represents the design by which Gadd34 stability was analysed in the presence and 
absence of Cdh1. HeLa cells were transfected either with control si RNA or Cdh1 si RNA in a final 
concentration of 5 nM. After 30 hrs transfection, HeLa cells were subjected to glucose deprivation for 
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16 hrs. Gadd34 stability was examined within 4 hrs after adding cycloheximide by western blot. B: 
Cdh1 depletion and Gadd34 levels were examined using Cdh1 and Gadd34 antibodies, respectively. 
Actin was used as loading control to normalise Gadd34 levels. C. The levels of Gadd34 were 
quantified in the presence and absence of Cdh1. The graph shows the quantification of 3 independent 
experiments. 
 
The data presented above indicated that depletion of Cdh1 results in stabilisation of 
Gadd34. 
Taken together, the analyses of Gadd34 levels and turnover indicate that the 
APC/CCdh1 is involved in targeting Gadd34 for degradation by the proteasome during 
and after releasing cells form ER stress (Fig 17 and 18). 
 
3. Subcellular localisation of Gadd34 and Cdh1 
The endogenous Gadd34 is principally associated with the ER, where Gadd34 
recruits the protein phosphatases 1 (PP1) to dephosphorylate the initiation factor and 
to resume protein synthesis (Brush et al 2003). Cdh1 is predominantly located to the 
nucleus (Zhou el al., 2003). Immunofluoresence microscopy analyses were carried 
out in order to analyse the subcellular localisation of these two proteins.  
 
3.1 Exogenous Cdh1 and Gadd34 are mainly located to two different  
compartments within the cell 
The subcellular localisation was assessed by immunofluoresence for exogenously 
expressed Gadd34 and Cdh1. HeLa cells were transiently cotransfected with Mt-
CDH1 and HA-GADD34. After 24 hrs, cells were fixed and co-stained with 
fluorescently labeled anti-Myc and anti-HA antibodies to determine the localisation of 
exogenous Cdh1 and Gadd34, respectively. 
Microscopy analysis showed that exogenously expressed Gadd34 was located to the 
cytoplasm close to the nucleus. Cdh1 was mainly nuclear with a slight localisation to 
the cytoplasm (Fig 19). 
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Fig. 19: Localisation of the exogenous Cdh1 and Gadd34 
HeLa cells seeded in 6 cm2 plate containing coverslips were co-transfected with 0,5 µg HA-Gadd34 
and 0,5 µg MT-Cdh1. Transfected cells were fixed next day and stained with alexa Fluor® 555 labeled 
anti-Myc, and alexa Fluor® 488 conjugated anti-HA antibodies. Dapi was used to stain nuclei. The 
localisation of Cdh1 and Gadd34 was examined under the fluorescence microscope.  
 
3.2 Exogenous Cdh1 localises to the cytoplasm under stress 
Conditions 
To assess the localisation of exogenous Cdh1 under ER stress conditions, HeLa 
cells were transfected with Mt-CDH1 and subjected in the next day to a glucose 
deprivation time course. The cells were fixed after 0, 8, 12 and 16 hrs glucose 
starvation and stained with alexa Fluor® 555-conjugated anti-Myc antibody in order 
to examine the localisation of the overexpressed Cdh1 under these conditions. To 
determine the integrity of the nucleus, cells were costained with anti-Eset antibody. 
Eset is a histone methyltransferases, which binds to DNA, mediates histone 
methylation and thereby regulates gene expression (Yang t al., 2002, Ryu et al., 
2006). 
The localisation of Cdh1 was examined under a fluorescence microscope before and 
after depriving cells of glucose. Notably, a mainly nuclear localisation pattern of Cdh1 
was seen with alexa Fluor® 555 labelled anti-Myc antibody in unstressed cells. The 
localisation of exogenous Cdh1 changed during glucose deprivation to become 
distributed both in the cytoplasm and the nucleus (Fig 20A). 
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Fig. 20: Exogenous Cdh1 shifts to the cytoplasm under stress conditions 
HeLa cells were transfected with 0,5 µg Mt-Cdh1and subjected to glucose deprivation in the next day. 
The localisation of Cdh1 was analysed for the indicated time points by immunofluoresence using Alexa 
Fluor® 555 labeled anti-Myc antibody. Cells were costained with Dapi to show the nuclei. The nuclear 
integrity was analysed using anti-Eset, which was visualised by alexa Fluor® 488 anti-rabbit 
secondary antibody. A. Shown are representative pictures taken at the indicated time points. B, 
Quantifications were performed to determine the percentage of Cdh1 transfected cells showing more 
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nuclear localisation of Cdh1 (N>C) and Cdh1 transfected cells showing about equal distribution to the 
nucleus and to the cytoplasm (N=C). The graph in B represents the quantification of 3 independents 
experiments. The graph in C represents the quantification of transfected cells with a defective nucleus 
in the same 3 independents experiments for the indicated time points. Statistical significance (P value) 
was determined using an unpaired t test (P<0,05) was considered as statistically significant).   
 
The localisation of exogenously expressed Cdh1 was quantified during glucose 
deprivation by counting cells showing a mainly nuclear localisation and cells showing 
a cytoplasmic and nuclear distribution of Cdh1. To exclude that the shuttling of 
exogenous Cdh1 to the cytoplasm can be caused by a loss of nuclear integrity, 
transfected cells with defect nucleus manifested by a cytoplasmic distribution of Eset 
were excluded from the quantifications (Fig 20B). In addition, cells with defect 
nucleus were counted (Fig 20C).  
 
The results of three independent experiments are illustrated in the graph 20B. Almost 
72 % of counted cells were showing a mainly nuclear localisation of exogenous 
Cdh1, when cells where cultivated in the presence of glucose. This percentage 
decreased significantly to reach 51 % after 8 hrs (P=0,04), 39 % after 12 hrs (P=0,01) 
and 33 % after 16 hrs glucose deprivation (P=0,0047) (Fig 12 B). 
The results indicated that stress conditions caused by glucose deprivation induced a 
partial cytoplasmic accumulation of Cdh1 (Fig 20). 
3.3 Cdh1 becomes mainly located to the nucleus during recovery from 
Stress 
The localisation of Cdh1 was as well analysed during recovery from stress. To this 
end, HeLa cells were transfected with MT-Cdh1. 24 hrs post transfection, cells were 
deprived of glucose for 16 hrs and released from stress in medium containing 
glucose. The localisation of the exogenous Cdh1 was analysed by immunostaining 
during the course of the experiment at the indicated time points in three independent 
experiments (Fig 21). 
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Fig. 21: Recovery from stress results in a nuclear relocalisation of 
overexpressed cdh1. 
 
HeLa cells were transfected with 0,5 µg MT-Cdh1. The localisation of Cdh1 was analysed by 
immunofluoresence. A. Representative pictures of cells analysed at the indicated time points, showing 
Cdh1 (stained with alexa® 555 labeled anti-Myc antibody) and the nucleus (stained with Dapi). 
Nuclear integrity was examined with anti-Eset, which was visualised by alexa Fluor® 488 anti-rabbit 
secondary antibody. B. The graph shows the localisation of exogenous cdh1 quantified in 3 
independents experiments. The graph in C represents the percentage of Cdh1 transfected cells with 
defect nucleus, which were not taken into consideration when Cdh1 localisation was examined. P 
value was determined using an unpaired t test. P<0,05 was considered as statistically significant.   
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Prior to glucose deprivation, exogenous Cdh1 was localised in 70 % of transfected 
cells primarily in the nucleus. As seen before after 16 hrs glucose deprivation, Cdh1 
became in about 30 % of transfected equally distributed between the cytoplasm and 
the nucleus. The observed distribution of exogenous Cdh1 changed significantly 
during recovery: 54 % of transfected cells were showing a nuclear localisation of 
Cdh1 after 2 hrs release (P= 0,0001), 57 % (P=0,0001) after 4 hrs and about 62 % 
after 24 hrs release (P=0,0136) (Fig 21).  
 
The results indicated that during recovery from stress Cdh1 become gradually more 
located to the nucleus again. 
3.4 Under ER stress, exogenous Cdh1 can still interact with the  
APC/C 
To analyse whether Cdh1 interacts with APC/C under ER stress conditions, 
immunoprecipitation assays were performed. For this purpose, HeLa cells were 
transfected with Mt-Cdh1. The next day, the cells were further cultivated for 16 hrs in 
medium either containing or lacking glucose. Cell extracts were subjected to 
immunoprecipitations using anti-Myc antibody and an anti-actin antibody was used as 
control. Immuno-complexes were detected by immunoblotting using anti-Myc and 
anti-Cdc27 antibodies (Fig 22).  
 
Immunoprecipitation using anti-Myc antibody shows that it was possible to bring 
Cdc27 down in lysates extracted from cell growing either in the presence of glucose 
or for 16 hrs in the absence of glucose. The interaction between overexpressed Cdh1 
and endogenous Cdc27 was specific, as no immunoprecipitates were detected after 
immunoprecipitation using actin antibody (Fig 22). 
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Fig. 22: Cdh1 interacts with the APC/C subunit Cdc27 in stressed and 
unstressed cells. 
 
HeLa cells were transfected with 1 µg Mt-Cdh1 and cultivated in the next day in medium either 
containing or lacking glucose for 16 hrs. The interaction between the exogenous Cdh1 and 
endogenous APC/C subunit Cdc27 was examined by immunoprecipitation using anti-Myc antibody. 
Immunoprecipitates were detected by western blot using specific antibodies. 
 
The result of the immunoprecipitation assay indicated that overexpressed Cdh1 was 
able to interact with endogenous Cdc27 in stressed and unstressed cells.  
 
4. Functional significance of the interaction between Gadd34  
and Cdh1 
The data presented above show that Cdh1 controls the Gadd34 turnover under ER 
stress conditions. Does Gadd34 interfere with the cell cycle progression and is 
therefore a target for degradation by APC/CCdh1?  Does Cdh1 control the ER stress 
response by modulating the Gadd34 turnover? Or both?  
 
98 
 
4.1 Accumulation of Gadd34 does not impede the cell cycle progression 
in HeLa cells 
Cell cycle analyses were performed under glucose deprivation in order to test the 
impact of the ER stress on the cell cycle progression. Therefore, HeLa cells were 
subjected to glucose deprivation and the cell cycle profiles were analysed by flow 
cytometry (Fig 23A). Protein levels of important regulators of the cell cycle were also 
assessed by western for the indicated time points (Fig 23B). 
 
Fig. 23: Glucose deprivation is not interfering with the cell cycle progression in 
HeLa cells. 
 
A. HeLa cells were subjected to glucose deprivation for the indicated time points and the cell cycle 
distribution was analysed by propidium iodide-based flow cytometry. B Western blot analyses were 
carried out using the appropriate antibodies to detect the level of cell cycle regulators during glucose 
deprivation and actin was used as control for equal loading. 
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The results of the flow cytometry analyses indicated that no cell cycle effect could be 
observed during glucose deprivation. Cell cycle arrest was not detected in HeLa cells 
even after depriving them of glucose for 20 hrs (Fig 23). In addition, the level of cyclin 
A and Cyclin B remained the same during glucose deprivation as analysed by 
immunobloting. Therefore, the accumulation of Gadd34 observed by cultivating HeLa 
cells in medium lacking glucose was not interfering with cell cycle progression (Fig 
23B). 
4.2 Glucose deprivation induces cell death in HeLa cells  
Microscopic analysis of HeLa cells cultivated for 16 to 20 hrs in the absence of 
glucose revealed that a percentage of the cells were dying. As a persistence of ER 
stress can contribute to cell death, it was interesting to determine the mechanism 
behind the death observed after glucose deprivation. 
 
                                      
 
Fig. 24: HeLa observed under light microscope after 16 hrs growths in medium 
not-containing glucose. 
 
The image represents the status of HeLa cells observed under light microscope after 16 hrs growth in 
medium lacking glucose. 
 
4.3 Glucose deprivation induces apoptosis in HeLa cells 
To examine whether the dying cells were undergoing apoptosis, annexin 
incorporation was tested in HeLa cells deprived of glucose. Therefore, HeLa cells 
were subjected to glucose deprivation for the indicated time points and then 
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incubated with annexin in combination with PI. Cells stained only with annexin are 
early apoptotic cells, whereas the uptake of PI indicates the loss of membrane 
integrity and pointed to terminal events of apoptosis (Fig 25). Detection of apoptotic 
cells was carried after 0, 12, 16 and 22 hrs glucose deprivation by flow cytometry (Fig 
25). 
 
 
 
Fig. 25: HeLa cells undergo apoptosis in the absence of glucose. 
HeLa cells were subjected to glucose deprivation. Quantification of apoptotic was carried out by flow 
cytometry after incubating cells with annexin and PI for the indicated time points. PI was used as 
indicator for late apoptosis (cells stained with PI and annexin). The lower left square indicates the 
percentage of living cells. The lower right and upper right show the percentage of early (positiv for 
annexin) and late (stained with annexin and PI) apoptotic cells, respectively. 
 
The analyses showed that 5 % of cells were stained with annexin and PI at 0 h time 
points. The percentage of early and late apoptotic cells (stained with PI and annexin) 
increased during glucose deprivation from 7 % after 12 hrs to reach 12 % after 22 hrs 
growth in medium lacking glucose (Fig 25 B). 
The results indicated that apoptosis is a cause of death observed during glucose 
deprivation. 
4.4 Autophagy is activated in HeLa cells subjected to glucose 
Deprivation 
Activation of autophagy could be another mechanism induced by glucose deprivation 
and finally resulting in death of HeLa cells. Therefore, analysis of of LC3 as an 
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autophagic marker was carried out in the course of the experiment. LC3 
(microtubule-associated protein1 light chain 3) is a protein, which is located diffusely 
in the cytoplasm under normal conditions. Activation of autophagy results in the 
translocation of the cytosolic form of LC3 (LC3-I) to the surface of autophagosomes, 
its binding to phosphatidylethanolamine and its cleavage to LC3-II. Investigation of 
the autophagic response under glucose starvation by western blot confirmed an early 
cleavage of LC3-I. 4 hrs after cultivating HeLa in medium lacking glucose, the 
conversion to LC3-II was observed. LCII could be seen also during the whole glucose 
deprivation time course (Fig 26).  
 
              
Fig. 26: Autophagy is activated in HeLa cells subjected to glucose deprivation. 
 
HeLa cells were subjected to glucose deprivation. The level of Gadd34 was analysed 
by western blotting using Gadd34 antibody. Cleavage of LC3 was examined by 
western blotting at the indicated time points. Actin served as loading control. 
 
Activation of autophagy in starved cells suggested that autophagy can protect 
starved cells from death and can also be another trigger for cell death observed in 
HeLa cells during glucose deprivation. 
5. The absence of Cdh1 sensitises cells to glucose deprivation   
Microscopic observations revealed that cells depleted of Cdh1 were showing more 
cell death when they were cultivated in the absence of glucose. These observations 
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suggested that Cdh1 might be involved in modulating the survival of cells undergoing 
ER stress. To verify this hypothesis, the sensitivity of HeLa cells to ER stress caused 
by glucose deprivation was analysed in the presence and absence of Cdh1 in more 
details. Therefore, HeLa cells were transfected either with Cdh1 si RNA or control si 
RNA, then in the next day subjected to glucose deprivation. The cell viability was 
assessed by trypan blue staining, for the indicated time points according to the 
scheme in figure 27A. Adherent and floating cells were collected for the 
quantification. Trypan blue was used to quantify all kind of death, which can be 
activated during glucose deprivation. Immunoblotting was performed to determine the 
levels of Gadd34 and to examine Cdh1 depletion (Fig 27B).  
Western blot analyses confirmed the depletion of Cdh1 in cells transfected with Cdh1 
si RNA. Gadd34 was highly induced during glucose deprivation in cells transfected 
with Cdh1 si RNA compared to cells transfected with control si RNA. In addition, 
Gadd34 started accumulating earlier in the absence of Cdh1.  A high induction was 
detected after 12 hrs in cells transfected with Cdh1 si RNA, whereas control si RNA 
transfected cells showed only a slight accumulation of Gadd34 at the same time point 
(Fig 27B). 
The percentage of living cells was quantified after 0, 12, 16 and 22 hrs glucose 
deprivation. In complete medium (0 hour time point), no significant difference in 
survival (P>0,5) was observed between cells transfected with control si RNA and 
Cdh1 si RNA (Fig 27C). Therefore, the percentage of viability was considered to be 
100 % in cells containing Cdh1 or depleted of it at the 0 hour time point (Fig 27C). 
The percentage of living cells was calculated by dividing the percentage of viability in 
each time point by the percentage of viability at the 0 h time point for both control and 
Cdh1 si RNA transfected cells. The graph in 25D illustrates the percentage of survival 
averaged from 3 independent experiments.  
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Fig. 27: Cdh1-depleted HeLa cells were more sensitive to glucose deprivation. 
A. The scheme represents the design by which the viability was determined after glucose deprivation 
in cells expressing and depleted of Cdh1. HeLa cells were transfected either with control si RNA or 
Cdh1 si RNA. 24 hrs after transfection, the cells were subjected to glucose deprivation for the 
indicated time points. B. The graph represents the percentage of living cells quantified by trypan blue. 
C. The levels of Gadd34 and Cdh1 were examined in lysates by western blotting at the indicated time 
points and actin served as control for equal loading. D: The graph shows the % of survival quantified 
with respect to non deprived cells in the presence and absence of Cdh1 in 3 independents 
experiments. Statistical significance (P value) was determined using an unpaired t test (P<0,05) was 
considered as statistically significant).   
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Quantification of 3 independent experiments was performed. In con si RNA 
transfected HeLa cells, 85 % of cells were viable after 12 hrs. The survival decreased 
to 76 % after 16 hrs and to 71 % after 22 hrs to reach about 48 % after 28 hrs 
glucose deprivation. In the absence of Cdh1, the sensitivity to glucose deprivation 
was more enhanced compared to con si RNA transfected HeLa cells. Quantification 
showed that about 79 % of cells were viable after 12 hrs glucose deprivation in Cdh1 
si RNA transfected cells, 64 % after 16 hrs, about 48 % after 22 hrs and reached 42 
% after 28 hrs growth in the absence of glucose (Fig 27D).  
The higher sensitivity to glucose deprivation in Cdh1 depleted cells was highly 
significant after 12 (P=0,0039), 22 hrs (P=0,001) glucose deprivation and significant 
after 16 hrs glucose deprivation (P=0,0171) (Fig 27D). 
Taken together, quantification of survival in cell depleted of Cdh1 subjected to 
glucose deprivation suggested the implication of Cdh1 in controlling the survival 
under ER stress conditions. 
6. Co-depletion of Gadd34 partially rescues from glucose 
deprivation induced cell death 
Gadd34 induction and even overexpression correlates with apoptosis (Hollander et al 
2003). It has been also reported that Gadd34 enhances autophagy during starvation 
(Nizam Uddin et al 2011). The data presented above strongly showed that Cdh1 
controls Gadd34 turnover and controls survival under ER stress conditions. The 
reports and the finding suggested that Cdh1 could be involved in controlling the 
survival under ER stress conditions through regulating Gadd34 turnover. Therefore 
and to verify this hypothesis, HeLa cells were transfected either with control si RNA, 
Cdh1 si RNA, Gadd34 si RNA or the combination Gadd34/ Cdh1 si RNA in 5 nM final 
concentration. The cells were subjected in the next day to glucose deprivation. The 
cell viability was assessed by trypan blue staining as it is described in the sheme Fig 
28A and the protein levels were detected by immunoblotting at the indicated time 
points (Fig 28B).  
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Fig. 28: Co-depletion of Gadd34 rescues HeLa cells partially from the death 
induced by glucose deprivation. 
 
A. HeLa cells were transfected either with control si RNA, Cdh1 si RNA, Gadd34 si RNA separately or 
with the combination of Cdh1 and Gadd34 si RNA in a 5 nM final concetration. 24 hrs after 
transfection, the cells were subjected to glucose deprivation and the cell viability was assessed by 
trypan blue staining at the indicated time points. B. Western blot analyses were pereformed to detect 
Cdh1 and Gadd34 levels. Actin was used as control for equal loading C. The graph represents the 
percentage of living cells quantified in 3 independent experiments by trypan blue in cells transfected 
with the indicated si RNAs and culivated in the presence of glucose. D. The graph represents 
quantification of survival in cells depleted either of Cdh1, or Gadd34 or both or cells transfected with 
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control si RNA avereged from 3 independent experiments. The statistics in Fig D were kindely done by 
Dr. Bousset.  
Quantification of cell viability was performed as described in the experiment before 
(3-3). The cell viability at the 0 h time point was considered as 100 % in all si RNA 
transfected cells as it was no significant difference to cell transfected with control si 
RNA (Fig 28C). 
The cell viability was quantified by trypan blue staining in each time point of glucose 
deprivation. The percentage of survival was calculated as done before. The graph in 
26B represents the average of 3 independent experiments (Fig 28D).  
Depletion of Gadd34 showed 90 % of viability after 12 hrs glucose deprivation. 
Almost no difference in the viability if compared to cells transfecetd with control si 
RNA and subjected to glucose deprivation for 12 hrs (90,67 %). A slight but not 
significant increase was observed after depleting Gadd34 in cells deprived of glucose 
for 16 and 22 hrs. The viabilty increased from 84 % in control si RNA transfected 
cells to 89,67 % in Gadd34 depleted cells after 16 hrs glucose deprivation and from 
74,67 % in the presence of Gadd34 to 80,67 % in Gadd34 si RNA transfected cells 
deprived of glucose for 22hrs (Fig 28D). 
In Cdh1 depleted cells, 85 % of cells were viable after 12 hrs growth in the absence 
of glucose, 74 % after 16 hrs and 59 % after 22 hrs. In this set of experiments, 
statistical analysis showed that the higher sensitivity to glucose deprivation observed 
here was significant at the 22 hrs time point (P=0,01) (Fig 28D).  
When Gadd34 and Cdh1 were co-depleted, the viability quantified after 12 hrs 
glucose deprivation increased to 92 % compared to Cdh1 si RNA transfected cells 
(85,33 %). This change was also observed after 16 and 22 hrs glucose deprivation. 
Statistical analyses revealead that co-depletion of Gadd34 and Cdh1 increased the 
viability of cells significantly from 74,33 % to 85,67 % (P=0,03), and from 59 % to 
69,33 % (P=0,02) when deprived of glucose for 16 and 22 hrs, respectively (Fig 
28D). At the 22 hrs time point a significante loss of viability was observed after 
depleting Cdh1, which could be nearly rescued by co-depleting Gadd34. 
The results indicated that co-depletion of Gadd34 rescued partially from the cell 
death observed during glucose deprivation (Fig 28D). 
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 In Parallel, flow cytometry analyses were carried out in order to determine the effect 
of the depletion of Gadd34, Cdh1 and both on the cell cycle progression in cells 
subjected to glucose deprivation for the indicated times (Fig 29). The results 
indicated that depletion of Gadd34, Cdh1 and both was not interfering with cell cycle 
progression upon stress caused by glucose deprivation (Fig 
29).
 
Fig. 29: Cell cycle progression is not affected during glucose deprivation in 
cells depleted of either Cdh1 or Gadd34 or both. 
 
Flow cytometry analyses were carried out to examine the effect of the depletion of Cdh1, Gadd34 and 
both on cell cycle progression during glucose starvation. 
Taken together, the data presented above indicate that accumulation or depletion of 
Gadd34 under ER stress conditions is not interfering with the cell cycle progression. 
Furthermore, they suggest that APC/CCdh1 is involved in controlling the cell survival 
under ER stress conditions through targeting Gadd34 for degradation by the 
proteasome. 
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7. Depletion of Cdh1 is not interfering with the recover of cells 
subjected to glucose deprivation 
HeLa cells subjected to glucose deprivation showed a decrease in cell viability. This 
reduction was more enhanced in the absence of Cdh1. Do stressed cells reach of 
point of no return after this they are not able to recover? And if this point exists, is it 
dependent on the presence or absence of Cdh1?  
To answer these questions, HeLa cells were transfected either with control si RNA or 
with Cdh1 si RNA. Next day, the cells were deprived of glucose for 0, 12, 16, 22 and 
28 hrs. To monitor the number of living cells, cells were counted after trypan blue 
staining during glucose deprivation for the indicated time points and after releasing 
these cells for 24 hrs in complete medium. Western blot analyses were performed to 
detect Gadd34 induction and to examine Cdh1 depletion during glucose deprivation 
and after release (Fig 30A). 
 
Fig. 30: HeLa cells were able to proliferate in the presence and absence of 
Cdh1 after releasing them from stress caused by glucose deprivation. 
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HeLa cells were transfected either with Cdh1 si RNA or with control si RNA. 24 hrs later, the cells were 
deprived of glucose for the indicated time points. At every time point cells were released for 24 hrs in 
complete medium for recovery. The cell viability was assessed before and after recover by trypan blue 
staining for the indicated time points. A. The levels of Gadd34 and Cdh1 were examined by western 
blotting using specific antibodies. Actin was used as a loading control. B. The graph shows the 
percentage of cells, depleted or containing Cdh1, which were able to recover after 24 hrs release from 
stress. The graph represents the mean of two independent experiments. 
 
Western blot analyses confirmed the depletion of Cdh1 in cells transfected with Cdh1 
si RNA and showed the Gadd34 induction during glucose deprivation in the presence 
and absence of Cdh1. After 24 hrs release, Gadd34 was completeley removed. This 
was observed both in control and Cdh1 si RNA transfected cells. A slight level of 
Gadd34 was detected in the absence of Cdh1 in cells releasd from 28 hrs glucose 
deprivation (Fig 30A).  
The relative cell number was calculated for each time point by dividing the number of 
living cells after 24 hrs release by the number of living cells before release. The 
graph in 30B represents this value averaged from 2 independent experiments in 
control and Cdh1 si RNA transfected cells for the indicated time points.  
The quantification showed that the cell number doubled within 24 hrs in cells growing 
in complete medium. The same was observed, when they were deprived of glucose 
for 12 hrs.  After been subjected to glucose deprivation for 16 to 22 hrs, the cells 
were still able to recover, but the relative cell number counted after 24 hrs release 
decreased from 2 (observed in earlier time points) to almost 1,5. This effect was 
observed both in the presence and absence of Cdh1. This decrease can be 
explained by the fact that some damaged cells were not able to recover and were 
eliminated within the 24 hrs release. After 28 hrs glucose deprivation, the cell number 
didn’t increase after addition of glucose. This suggests that the cells were not able to 
recover and to proliferate both in control and Cdh1 si RNA transfected cells (Fig 
30B).  
The results indicated that HeLa cells were able to recover up to 22 hrs glucose 
deprivation both in the presence and absence of Cdh1. Furthermore, the cells had 
reached a point of no-return after been deprived of glucose for longer than 22 hrs as 
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seen at the 28 hrs time point. At this point, HeLa cells didn’t recover and showed a 
decrease in the the relative cell number counted after 24 hrs release in complete 
medium. This effect was not dependent on Cdh1, as it was also observed in control si 
RNA transfected cells. 
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V. Discussion 
Proteasomal dependent degradation of Gadd34 has been previously documented 
(Brusch & Shenolikar 2008). However, the ubiquitination system involved in this 
degradation is up to now unknown. The results presented in this work give the first 
evidence for the specific interaction between Gadd34 and Cdh1 and the direct 
involvement of Cdh1 in the Gadd34 turnover. In this function Cdh1 controls the 
survival of cells subjected to ER stress. By defining the ER stress protein Gadd34 as 
a new interacting partner of the cell cycle regulator, it was also possible to 
characterise a new function played by APC/CCdh1 under ER stress conditions. 
 
1. Gadd34 is a new target of the APC/CCdh1   
In the first part of this work, the interaction previously discovered in a yeast-two-
hybrid screen between Cdh1 and Gadd34 was analysed in human cells. Co-
immunoprecipitation assays demonstrated the specific interaction between Gadd34 
and Cdh1 in mammalian cells after overexpression (Fig 1). Furthermore, and in 
agreement with the results of the yeast two-hybrid screens, the C-terminals of 
Gadd34 was sufficient for the interaction with Cdh1. This was concluded after co-
immunoprecipitating exogenous Cdh1 with the 3 deletion mutants (Fig 2-3). To 
exclude a contribution of the N-terminus in the interaction with Cdh1, a construct 
lacking the C-terminus (Gadd34 1-483 aa) is already cloned by Dr. Bousset in HA-
Tag expressing vector and will be used in co-immunoprecipitation assays. The C-
terminal region of Gadd34 is also interacting with most important regulators of its 
activities (Hollander et al., 2003). The observation that the D-Box located at the C-
terminal was not found to be conserved between human, rat and mouse suggests 
that Cdh1 may need a motif other than D-Box for Gadd34 recognition. A-box 
(RxLxPSN), O-box, and CRY box (CRYxPS) are additional destruction motifs 
recognised by Cdh1 (Leuken et al., 2006). There is also evidence suggesting that 
Cdh1 in some cases needs more than one motif for recognising its targets. The 
Aurora B kinase is an example of substrates recognised by APC/CCdh1 via KEN and 
A-box (RxLxPSN) (Nguyen, et al., 2005). Therefore, mutating this motif will help to 
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further test the importance of the D-Box at position (526-529) in the recognition of 
Gadd34 by Cdh1. 
The function of APC/CCdh1 as an E3 ligase in the ubiquitin pathway suggested also 
that this interaction could result in Gadd34 ubiquitination. This hypothesis was tested 
using a His-ubiquitination assay. This assay is an efficient system to detect E3 ligase 
function toward specific substrates (Bloom and Pagano 2005). The detection of 
protein ubiquitination occurs after transient expression of the E3 ligase, the target 
protein and His-Ubiquitin. Increasing the level of the E3 ligase should result in 
increasing the ubiquitination of the substrate. Furthermore, inactivation of the E3 
ligase can strengthen the argument for a direct ubiquitination of the substrate by the 
tested E3 ligase. The performed His-ubiquitination assays showed that Gadd34 
ubiquitination was enhanced by Cdh1 in a dose dependent manner. An effect, which 
was reversed after overexpressing Cdh1 inhibitors Emi1 and the N-terminal of Cdh1 
(N125) thereby giving evidence for the direct involvement of Cdh1 in Gadd34 
ubiquitination. The ubiquitination of Gadd34 was more inhibited by the dominant 
negative Cdh1 (N125) than Emi1. The difference in the level of Gadd34 ubiquitination 
could be a result of the difference in the expression level between Emi1 and Cdh1 as 
it was seen in the western blot (Fig 4). It has been already reported that the C-
terminal region was the part of Gadd34, which is subjected to ubiquitination 
(Watanabe et al., 2007). The data presented above support this result as the C-
terminal was the part of Gadd34 interacting with Cdh1. Overexpression of the C-
terminal region of Gadd34 in combination with Cdh1 and His-ubiquitin could be an 
additional experiment to further show that the C-terminus is the part of Gadd34, 
which is getting ubiquitinated by Cdh1. It was suggested that a construct lacking the 
first 60 amino acids at the N-terminal (Gadd34 (-60)) was seen to be more stable 
compared to the full length Gadd34 due to different localisation (Brush & Shenolikar 
2008). This observation should be taken into consideration, when analysing the 
ubiquitination of Gadd34 deletion constructs. 
2. Cdh1 regulates Gadd34 turnover under physiological  
Conditions 
The functional significance of the interaction between the cell cycle protein Cdh1 and 
the ER stress protein Gadd34 was analysed under conditions causing ER stress. 
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Physiological and pharmaceutical stress inducers were tested during this work in 
order to induce ER stress and thereby to accumulate Gadd34 (Fig 5). In line with 
previously published data glucose deprivation was effective in inducing Gadd34 in 
HeLa and in other human cell lines (Fig 5) (Diehl 2006, Brush & Shenolikhar 2008). 
The results also indicated that Gadd34 was not expressed in unstressed HeLa and 
the other tested cells (Fig 6). Its transcription as analysed by RT-PCR started 
between 4 and 8 hrs glucose deprivation when eIF2- was higher phosphorylated 
(Fig 6). It has been reported that the expression of Gadd34 is controlled by the 
transcription factor ATF4. Both ATF4 and Gadd34 are selectively translated when 
eIF2- is phosphorylated in a 5’UTR dependent mechanism (Ma & Hendershost 
2003, Ron 2002, Lee et al., 2009). The decrease in eIF2- phosphorylation observed 
later during glucose deprivation could be attributed to the feedback loop played by 
Gadd34 by assembling the phosphatase type I (Fig 6). In this function Gadd34 allows 
partial translational recovery and strengthens the ER stress response. This leads to 
more expression of many ER stress inducible-genes including Bip, ATF4 and Chop 
(Novoa et al. 2003). This could explain the increased levels of Chop observed later 
during glucose deprivation (Fig 6). Other studies showed that ATF4 induces the 
expression of Chop, which leads in turn to the accumulation of Gadd34. Tunicamycin 
treated Chop-/- cells showed a reduced expression of Gadd34 (Marciniak et al., 
2004). Thus, Chop was placed upstream of Gadd34, which can also be an argument 
for the high accumulation of Gadd34 observed late during ER stress (Fig 6) (Harding 
et al., 2000, Kojima et al., 2003. Marciniak et al., 2004, Zhang & Kaufman 2008). 
Consistent with a previous study performed by Brush and Shenolikar (Brush & 
Shenolikar 2008), the accumulation of Gadd34 was reversible after removal of stress 
(Fig 7) and Gadd34 was found to be a short lived protein (Half-life< 30 min) (Fig 8A). 
Together, these data suggest the existence of transcriptional and translational 
regulation, which allows Gadd34 as an ER stress inducible gene to be exclusively 
and selectively expressed and translated under ER stress conditions. Inactivating 
Cdh1 activity resulted in a higher accumulation of Gadd34 in ER stressed cells, 
slower reduction of Gadd34 during the release (Fig 9) and extended Gadd34 half-life 
(Half-life> 4hrs) (Fig 10). These data implicate strongly Cdh1 in the regulation of 
Gadd34 turnover in stressed cells and after releasing cells from stress thereby giving 
the first evidence that APC/CCdh1 is the E3 ligase involved in the proteasomal 
degradation of Gadd34 (Fig 9-10). 
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Gadd34 was not completely stable in cells depleted of Cdh1 (Fig 9-10). It is possible 
that low levels of Cdh1 remaining after depletion, which were not detected by western 
blotting, can degrade Gadd34. It can also be explained by the existence of another 
E3 ligase, which can be activated to regulate the turnover of Gadd34 in the absence 
of Cdh1. Proteins directed for proteasomal degradation by two different ligases have 
been already documented. For example, SAS6 proteasomal dependent degradation 
is controlled by APC/CCdh1 during G1 (Tang et al., 2009) and by SCFFbxw5, recently 
discovered in our group, during S phase (Puklowski et al., 2011). Preliminary data 
showed that overexpressed Cdc20 can interact with Gadd34 and resulted also in its 
ubiquitination (data not shown in this work). These observations suggest that Cdc20 
could possibly compensate for the loss of Cdh1 and require further investigations. 
 
3. Gadd34 and Cdh1 localise to the cytoplasm under ER stress   
Conditions 
In the absence of specific antibodies suitable for immunofluoresence to recognise 
endogenous Gadd34 and Cdh1, analysis of the subcellular localisation of Cdh1 and 
Gadd34 was carried out for exogenously tagged expressed proteins. Consistent with 
previous data, the result of the immunostaining revealed that Cdh1 was mainly 
nuclear with a slight staining in the cytoplasm in unstressed cells (Fig 11). Gadd34 
was located in the cytoplasm close to nucleus (Fig 11). The use of specific 
fluorescent dyes like DioC6 staining the ER or specific antibodies that recognise ER-
associated proteins like anti-Calnexin is required to further indicate that Gadd34 is 
localised to the ER. The localisation of Gadd34 was analysed in detail in a recent 
study performed by Zhou and colleagues. In this work, they described a hydrophobic 
region located between the 16 and 65 amino acids in targeting Gadd34 to the ER. 
This sequence is highly conserved in mammalians species. Deletion of this sequence 
or substitution of valine located at position 25 to arginine resulted in cytosolic 
distribution of Gadd34. The localisation of Gadd34 to the ER was seen to be 
important for its proteasomal degradation, as the cytsolic form of Gadd34 was more 
stable than the wild type (Zhou at al., 2011).  
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Analyses of the localisation of exogenous Cdh1 revealed that Cdh1 was mainly 
located to the nucleus in unstressed cells. Depriving cells of glucose resulted in an 
equal distribution of Cdh1 between the nucleus and the cytoplasm. This change in 
the localisation was significant (Fig 12). After releasing cells from the stress caused 
by glucose deprivation, this localisation changed significantly to become again mainly 
nuclear (Fig 13).  
Eset was used as a control to examine nuclear integrity under glucose deprivation. 
The results indicated that only the localisation of Cdh1 was changed during glucose 
deprivation. Further investigations are required to test whether the effect observed is 
due to overexpression of CDH1 or can be seen in endogenous protein.  
The subcellular localisation of Cdh1 is cell cycle dependent. Cdh1 is phosphorylated 
and located to the cytoplasm during S, G2 and early M, whereas unphosphorylated 
Cdh1 is mainly located to the nucleus at the mitotic exit and during G1 (Kramer et al., 
2000). The mechanism explaining the cytoplasmic distribution of Cdh1 under stress 
conditions might be different from the cell cycle regulation.  Changes in protein 
localisation following stress have already been reported in the literature. Stress 
caused by DNA damage was seen to promote the nuclear import of p53, which is 
predominantly localised and degraded in the cytoplam after translation in unstressed 
cells (Marchenko, et al., 2010). Genotoxic stress promotes also dephosphorylation of 
Cdh1, which becomes nuclear in order to reactivate the APC/C and thereby to control 
the G2 arrest in DNA damaged cells (Basserman et al., 2008). But so far there are no 
reports on cytoplasmic distribution of Cdh1 under any from of stress. An active 
cytoplasmic isoform of Cdh1 lacking the nuclear localisation side was already 
described but the conditions allowing the translation of this isoform are not known 
(Zhou et al., 2003). It could also be possible that the cytoplasmic Cdh1 observed 
under ER stress is an isoform of Cdh1, which is selectively translated under ER 
stress. Indeed, examples of protein isoforms translated under ER stress are already 
documented. p53/47 for example is an isoform of p53 translated selectively under ER 
stress (Bourougaa et al., 2010). 
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4. Modulation of Gadd34 turnover highlights a new function of   
Cdh1 during ER stress 
4.1 ER stress caused by glucose deprivation is not affecting the cell 
cycle  progression 
Flow cytometry analyses revealed that depriving HeLa cells of glucose cells up to 22 
hrs was not resulting in any obvious cell cycle effect (Fig 20 - 27). A reduced 
proliferation due to a G1 arrest was already reported in ER stressed cells (Brewer et 
al., 1999, 2000). Glucose limitation was also suggested to activate a p53-dependent 
restriction checkpoint at the G1/S boundary and cell cycle arrest (Jones et al., 2005. 
See introduction: 5- UPR and cell cycle). The dependency of the arrest observed on 
p53 can be an explanation for the absence of G1 arrest during glucose deprivation. 
In fact, p53 is instable due to an enhanced degradation by the of p53 protein by the 
E6 viral oncoprotein expressed in HeLa cells used in this work (Wesierska-Gadek et 
al., 2000). 
 
4.2 Cdh1 modulates the survival under ER stress through targeting    
Gadd34 
Quantification of survival revealed that depletion of Cdh1 significantly sensitised 
HeLa cells to cell death during the course of glucose deprivation. Gadd34 was also 
detected earlier and to higher level in cell depleted of Cdh1 compared to control si 
RNA transfected cells when they were subjected to glucose deprivation (Fig 25). 
These results suggested that the absence of Cdh1 as the E3 ligase controlling 
Gadd34 turnover could be a reason for the increased cells death observed during 
glucose deprivation. This hypothesis was tested by analysing the effect of depleting 
Cdh1, Gadd34 and the co-depleting both Cdh1 and Gadd34 on the survival of 
stressed cells. In this set of experiments Cdh1 depleted cells were seen to be 
sensitive to glucose deprivation compared to control si RNA transfected cells (Fig 
26). This sensitivity was only significant at the 22 hrs time point which was not the 
case for the previous experiments (Fig 25). A variation in the cell culture conditions 
could be an explanation for the difference observed between the results illustrated in 
Figure 25 and 26. Depletion of Gadd34 increased slightly but not significantly the 
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survival in cells subjected to glucose deprivation (Fig 26). The sensitivity of Cdh1 
depleted cells to glucose deprivation was significantly reduced after co-depleting 
Gadd34 and Cdh1 in cells subjected to glucose deprivation for 16 and 22 hrs. 
Therefore it is very likely that Cdh1 is involved in the modulation of cell survival under 
ER stress conditions by controlling the level of Gadd34 (Fig 26).   
An involvement of Gadd34 in cell death was already documented. It has been 
reported that overexpression of Gadd34 correlates with and even enhances 
apoptosis (Adler et al., 1999, Hollander et al., 1997, 2001, 2003). This function can 
be negatively modulated through binding of HRX (expressed as a result of 
chromosomal translocation in Leukemia) to the C-terminus of Gadd34 (Adler et al., 
1999) and through phosphorylation by Lyn (Scr-related protein tyrosine kinase 
activated during DNA damage) (Grishin et al., 2001). The apoptotic function played 
by Gadd34 was also described in prolonged ER stress. Gadd34C/C mutant mice 
(homozygous for a mutation that eliminates the C-terminal region of Gadd34 required 
for the binding to the phosphatase type1) were resistant to apoptosis induced in 
kidney by tunicamycin treatment. This could be most likely due to a prolonged shut 
off of protein synthesis (Marciniak et al., 2004). Prolonged inhibition of protein 
synthesis might relieve in some context the stressed cells from an overload of 
additional newly synthesised proteins and even the expression of other pro-apoptotic 
proteins like Chop. But it can also block the expression of pro-survival proteins and 
promote thereby cell death. Gadd34C/C mousse fibroblasts were more sensitive to 
thapsigargin induced cell death. An effect, which correlated with impaired expression 
of ER stress-inducible chaperones due to a persistent inhibition of protein synthesis 
(Novoa et al., 2003).  
The finding presented in my thesis suggested a new function of Cdh1 under ER 
stress. In this function Cdh1 protects cells from cell death activated during ER stress. 
A recent study supports also this notion, as Cdh1 was shown to control the 
degradation of TRB3 another ER stress protein (Ohoka et al., 2010). TRB3 is also 
induced via the ATF4 - Chop pathway and promotes cell death under prolonged ER 
stress conditions (Ohoka et al., 2005). Therefore, Cdh1 might play a more general 
role in survival after ER stress response. 
Evidences suggest that the balance between survival and death during ER stress is 
maintained by intrinsic instability of mediators of cell death during ER stress response 
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such as Chop and Gadd34. Prolonged ER stress increases the level of these 
proteins and promotes death of ER-stressed cells (Rutkowski et al., 2006, Ron & 
Walter 2007). The finding presented in this work and the above mentioned reports 
strongly suggest that Cdh1 can be an inhibitor of the switch from the pro-survival to 
pro-death response of the ER stress response. This function can be achieved 
through reducing the level of pro-apoptotic mediators through targeting them for 
degradation by the proteasome. 
The rescue observed after depletion of Gadd34 was only partial during the course of 
the experiments (Fig 26). This could be explained by the existence of other pro-death 
proteins activated by the other axes of the UPR. JNK activated by the IRE1 signalling 
pathway for example can activate apoptosis though phosphorylation of Bcl2 family 
proteins and subsequent release of Bax and Bid (Lai et al 2007, Lamara & Scorrano 
2009). Phosphorylation of Bcl2 can also promote autophagic cells death (Verfaillie el 
al 2010). Furthermore, Chop can also be induced by pathways other than PERK (see 
introduction Fig 7) and promote apoptosis. This is in line with the observation that 
cells were not completely protected from the cell death observed when Gadd34 was 
depleted (Fig 26).  
Both autophagy and apoptosis were activated during glucose deprivation (Fig 22-23). 
However, it was not clear whether autophagy is activated as cytoprotective or 
cytotoxic mechanisms. Therefore, inactivation of autophagy using specific inhibitors 
like 3-methyladenine or by targeting the expression of autophagic genes using 
specific si RNA can be useful to analyse whether autophagy promotes survival or 
eliminates damaged cells during glucose deprivation and thereby to characterise the 
mechanism of the cell death activated under these conditions. 
The absence of Cdh1 sensitised cells significantly to glucose deprivation without 
affecting their ability to recover and to proliferate after removal of stress (Fig 28). 
Cdh1 depleted cells deprived of glucose for 16 hrs reduced Gadd34 slowly in the first 
3 hrs of release (Fig 9). In these cells, the high accumulation of Gadd34 observed 
within the first hours of release was not interfering with the recovery. This can be 
explained by the fact that as long as a cell didn’t reach the point of no-return they still 
have the opportunity to recover and to divide. Furthermore, the cells might not 
accumulate Gadd34 to the same levels. Cells with a high level of Gadd34 will die 
within the release and cells with low levels can most likely activate other mechanism 
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to degrade Gadd34 and thereby to survive and proliferate. In fact, Gadd34 was seen 
to be completely removed in these cells after 24 hrs release (Fig 28). This effect was 
also observed when cells were stressed up to 22 hrs (Fig 28). 
After 12 hrs glucose deprivation, the relative cell number doubled in a similar way as 
cell growing in the presence of glucose. A decrease in the relative cell number was 
observed after releasing cells from 16 and 22 hrs glucose deprivation (Fig 28). This 
can be explained by the fact that some cells which were determined to die before the 
release and were not detected with trypan blue staining (early apoptotic for example) 
were eliminated within the 24 hrs of release. Quantification of apoptotic cells with 
annexin before and after the release could be used to quantify these cells. 
The results presented by this work revealed the importance of Cdh1 in controlling the 
ER stress response through targeting Gadd34 for degradation, whereas the release 
from stress was not seen to be dependent on this function.  
 
5. Targeting Cdh1 can be a promising novel strategy for cancer  
Treatment 
The results discussed above could be exploited for inhibiting tumour growth. For their 
energy supply, tumour cells are more dependent on glycolysis and therefore they are 
characterised by an increased glucose uptake compared to normal cells (Garber 
2006, Simons et al., 2009). In tumour cells a decrease in ATP can leads to apoptosis 
(Heiden et al., 2009). An increased activation of autophagy in the absence of glucose 
can also result in cell death (Dang et al., 2011). Data pointed out that manipulation of 
glucose metabolism can be effective in eliminating cancer cells (Garber 2006). In 
addition, that some drugs were more effective in eradicating tumours, when cells 
were deprived of glucose. This was for example observed with Versipelostatin and 
biguanides, inhibitors of GRP78, ATF4 and XBP1, when they were combined with 
glucose deprivation (Saito et al., 2009).  
The effect of Cdh1 depletion in increasing cell death of HeLa cells subjected to 
glucose deprivation was an important result presented in this work. This result 
suggests that strategies to either downregulate or inhibit Cdh1 can represent a 
promising therapeutic approach in the context of tumours therapy. This idea is 
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supported by other growing evidences, which point out to the importance of inhibiting 
proteolysis as target for cancer treatment. Interfering with the activity of SCF by down 
regulating Skp2 either by si RNA or using specific inhibitors can induce either 
apoptosis or growth arrest in tumour cells (Wäsch & Engelbert 2005). Other studies 
revealed that inhibition of Cdc20 can be a new tool in targeting cancer cells. 
Depletion of Cdc20 was observed to induce cell cycle arrest at G2/M and to inhibit 
cell growth (Kidokoro et al., 2008). In addition, our group and others demonstrated 
the importance of targeting the proteasome for cancer therapy. Argyrin discovered by 
our group, because of its specificity towards p27, is a very promising future drug, 
showing an in vivo antitumour activity by inhibiting the proteasome (Nickeleit et al., 
2008).   
ER stress is activated in solid tumours due to hypoxia and nutrients starvation. 
Depletion of Cdh1 using small drugs could be used to increase the ER stress 
response. This effect can be more enhanced if combined with glucose deprivation. 
Therefore combining Cdh1 inhibitors with glucose deprivation or inhibitors of glucose 
metabolism can be a promising strategy to further stress and to eliminate cancer 
cells. The use of inhibitors of glucose metabolism is suggested as it is to some 
extend not possible to deprive cell completely of glucose in vivo. Treatment with 2-
deoxy-D-glucose (2DG) was seen to be effective in inhibiting glucose metabolism by 
competing with glucose for uptake and phosphorylation at the entry of glycolysis 
(Simons et al., 2009).  
Inhibition of Cdh1 using small drugs can induce senescence in non-tumour cells and 
can affect many aspects of APC/CCdh1 functions in terminally differentiated cells (see 
introduction: 6-Life without Cdh1). With respect to the haplo-insufficient tumour 
suppressor function played by Cdh1, the use of inhibitors that partially inactivate 
APC/CCdh1 can result in developing other tumours (Garcia-Higuera et al., 2008). 
Therefore, targeting tumours cells exclusively and selectively can be effective in 
reducing any side effects caused by inhibiting Cdh1 during cancer therapy. This 
could be achieved for example by combining Cdh1 inhibitor with specific monoclonal 
antibodies recognising markers specifically expressed on the surface of tumours (like 
Bip). Thus, healthy cells would not be affected (Verfaillie et al., 2010).  
An in vivo tumour model will help to explore and to exploit the finding presented in 
this work. Multiple myeloma cells are characterised by increased activation of the ER 
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stress response to induce XBP-1, which is necessary for plasma cell differentiation 
and immunoglobulin secretion (Lee et al., 2003). Myeloma xenograph models are 
already documented and were used in several in vivo studies (Pan et al., 2011, 
Papandreou et al., 2011). This system can be useful for exploring the effect of Cdh1 
depletion on tumours growth and survival. This can be achieved for example through 
generating multiple myeloma stably expressing inducible Cdh1 si RNA, which can be 
xenographed to nude mice. If the in vivo analyses confirm the importance of 
depleting Cdh1 in modulating survival of tumour cells, this system can be exploited 
for screening for small molecules inhibiting Cdh1 or stabilising Gadd34, which could 
be in combination with inhibitors of glucose metabolism an effective tool for treating 
cancer. 
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VI. List of abbreviation 
A 
APS 
Bp 
BSA 
cDNA 
°C 
CsCL 
Da 
dd 
DAPI 
DEPC 
DMEM 
DMSO 
DNA 
DNase 
DOC 
dNTPs 
EDTA 
EGTA 
et al 
Ampere 
Ammonium persulfate  
Base pair 
Bovine serum albumin 
Complementary DNA 
Degree celsius 
Cesium chloride 
Dalton 
Double distillate  
4´,6-diamidino-2-phenylindole 
Diethyl pyrcarbonat 
Dulbecoo’s modified egal medium 
Dimethylsulfoxid 
Desoxyribonucleic acid 
Deoxyribonuclease 
Deoxycholic acid 
2-deoxyribonucleotides  
Ethylene diamine tetra-acetic acid 
Ethylene glycol tetraacetic acid 
and others 
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FACS 
FCS 
Fig 
G 
GD 
Glu 
HEPS 
Hrs 
H2O2 
HPRT 
HRP 
mRNA 
kb 
kDa 
M 
mA 
MG132 
min 
mRNA 
ml 
n 
NaF 
NP-40 
Nr 
Fluoresence activated cell sorting 
Fetal calf serum 
Figure 
Gram 
Glucose deprivation 
Glucose 
4-(2-Hydroxyethyl)-1-piperzine-N-ethanesulfonic acid 
Hours 
Hydrogen peroxide 
Hypoxantin-phosphoribosyl-transferase 
Horseradish peroxidase 
Messenger RNA 
Kilobase 
Kilodalton 
Molar 
Milli-ampere 
z-leu-leu-leu-al 
Minute 
Messenger RNA 
Milliliter 
Nano (10-9) 
Sodium fluoride 
Nonidet P-40 
Nummer 
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PBS 
PCR 
RNA 
RNase 
RT 
SB 
siRNA 
Rpm 
SDS 
SDS-PAGE 
TBE 
TE 
TEMED 
TNT 
Tris 
g 
g 
M 
PFA 
PAA 
V 
Phosphate-buffered saline 
Polymerase chain reaction 
Ribonucleic acid 
Ribonuclease 
Room temperature 
Sample buffer 
Small interfering RNA 
Rotation per minute 
Sodium dodecyl sulfate 
sodium dodecyl sulfate polyacrylamide gel electrophoresis 
Tris-borate-EDTA 
Tris EDTA 
(N, N, N’, N’- tetramethyethylenediamine 
Tris-NaCL-tween 
Tris-(hydroxymethyl) aminomethane 
Micro (10-6) 
Microgram 
Micromolar 
Paraformaldehyde 
Polyacrylamid 
Volt 
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